ethinyl estradiol has been researched along with gestodene in 269 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 31 (11.52) | 18.7374 |
| 1990's | 119 (44.24) | 18.2507 |
| 2000's | 73 (27.14) | 29.6817 |
| 2010's | 45 (16.73) | 24.3611 |
| 2020's | 1 (0.37) | 2.80 |
| Authors | Studies |
|---|---|
| Dansette, PM; Fontana, E; Poli, SM | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Lachnit, U; Unger, R; Weber-Diehl, F | 1 |
| Angel, JL; Chez, RA; Hunter-Bonner, DL; O'Brien, WF; Smalling, S; Spellacy, WN; Tsibris, JC | 1 |
| Atsma, WJ; Fioretti, P; Fruzzetti, F; Lammers, P; Melis, GB; Nicoletti, I; Ricci, C | 1 |
| D'Arrigo, F; Granata, A; Granese, D; Nicita, R; Panacea, A; Pullè, C; Sobbrio, GA; Trimarchi, F | 1 |
| Back, DJ; Green, S; Orme, M; Ward, S | 1 |
| Pedersen, RG; Petersen, KR; Skouby, SO | 1 |
| Babor, P; Feichtinger, W; Herczeg, KM; Heyda, M; Hoffmann, R; Plöckinger, B; Steinhauser, B | 1 |
| Back, D; Kuhnz, W; Louton, T; Power, J; Schütt, B | 1 |
| Gansau, C; Kuhnz, W; Louton, T; Mahler, M; Sostarek, D | 1 |
| Buytaert, P; Renier, M | 1 |
| Bordon, R; Carta, Q; Gennarelli, GL; Trossarelli, GF | 1 |
| Albring, M; Brill, K; Norpoth, T; Schnitker, J | 1 |
| Borggaard, B; Bremmelgaard, A; Kjaer, A; Lebech, AM; Refn, H; Schierup, L | 1 |
| Thomas, K; Vankrieken, L | 1 |
| Gross, W; Heidt, F; Jung-Hoffmann, C; Kuhl, H; März, W | 2 |
| Brill, K; Heithecker, R; Hümpel, M; Kuhnz, W; Louton, T; Pfeffer, M; Schütt, B; Seifert, W; Steinberg, B; Täuber, U | 1 |
| de Boer, R; Dersjant-Roorda, MC; Gevers Leuven, JA; Havekes, L; Helmerhorst, FM; Neymeyer-Leloux, A | 1 |
| Bonnar, J; Daly, L | 1 |
| Brill, K; Heithecker, R; Hümpel, M; Kuhnz, W; Louton, T; Pfeffer, M; Steinberg, B; Tüber, U | 1 |
| Gansau, C; Hümpel, M; Kuhnz, W; Louton, T; Schütt, B; Steinberg, B | 1 |
| de Boer, R; Dersjant-Roorda, MC; Havekes, LM; Helmerhorst, FM; Leuven, JA; Neymeyer-Leloux, A | 1 |
| Bauer, K; Jürgensen, R; Kaffarnik, H; Steinmetz, A | 1 |
| Assendorp, R; Bergink, W; Kloosterboer, L; Qvist, I; van Lier, W; Voortman, G | 1 |
| Jung-Hoffman, C; Kuhl, H | 1 |
| Jung-Hoffmann, C; Kuhl, H | 2 |
| Bernsen, MJ; Dersjant-Roorda, MC; Gevers Leuven, JA; Harthoorn-Lasthuizen, EJ; Helmerhorst, FM; Kluft, C; Peters, FP | 1 |
| Dewsbury, JA; Kirkman, RJ; Loudon, NB | 1 |
| Brill, K; Düsterberg, B | 2 |
| Hümpel, M; Kuhnz, W; Täuber, U | 1 |
| Guengerich, FP | 1 |
| al-Yacoub, G; Kuhnz, W; Pfeffer, M | 1 |
| Senèze, J | 1 |
| Maltau, JM; Oian, P; Omsjø, IH; Osterud, B | 1 |
| Bertolotto, A; Fioretti, P; Fruzzetti, F; Giampietro, O; Melis, G; Miccoli, R; Navalesi, R; Orlandi, MC; Ricci, C | 1 |
| Haspels, AA; Kloosterboer, HJ; van der Berg, H; van der Vange, N | 1 |
| Florio, V; Morini, A; Mossa, B; Roscetti, C | 1 |
| Thomas, KH; Vankrieken, L | 1 |
| Benagiano, G | 1 |
| Christie, T | 1 |
| de Pagter, HA; Dersjant-Roorda, MA; Helmerhorst, FA; Leuven, JA; Roelofsen, J | 1 |
| Agoestina, T; Hoppe, G; Sabarudin, U | 1 |
| Cerri, M; Fioretti, P; Fruzzetti, F; Melis, GB; Miccoli, R; Navalesi, R; Ricci, C | 1 |
| Heinzl, S | 1 |
| Hümpel, M; Nieuweboer, B; Tack, J; Täuber, U; Wendt, H | 1 |
| Fotherby, K; Lee, B; Longthorne, PN; Trayner, I; Watson, HR | 1 |
| Gaspard, UJ; Lepot, MR | 1 |
| Bonnar, J; Carroll, E; Daly, L | 1 |
| Harenberg, J; Kohlmeier, M; Rabe, T; Runnebaum, B; Weicker, H | 1 |
| Skouby, SO | 1 |
| Huber, J; Spona, J | 1 |
| Mall-Haefeli, M | 1 |
| Rabe, T; Runnebaum, B | 1 |
| Balestreri, R; Bertolini, S; Cordera, R; Croce, S; De Cecco, L; Elicio, N; Gapitanio, GL; Montagna, G; Saturnino, M | 1 |
| Fotherby, K | 1 |
| Dreisler, A; Kühl, C; Rubeck Petersen, K; Skouby, SO; Svenstrup, B | 1 |
| Heidt, F; Jung-Hoffmann, C; Kuhl, H | 2 |
| Gillmer, MD | 1 |
| Cremer, P; Vekemans, M | 1 |
| Anthony, F; Dennis, KJ; Stickland, J; Tolowinska, IY | 1 |
| Hoppe, G | 1 |
| Carmassi, F; Fioretti, P; Fruzzetti, F; Melis, GB; Paoletti, AM | 1 |
| Gurewich, V; Jick, H; Jick, SS; Myers, MW; Vasilakis, C | 1 |
| Düsterberg, B; Fuchs, N; Mühe, B; Weber-Diehl, F | 1 |
| Jung-Hoffmann, C; Kuhl, H; Wiegratz, I | 1 |
| Kuhnz, W; Löfberg, B | 1 |
| Banfield, CR; Colucci, RD; Glue, P; Haring, P; Lin, CC; Meehan, JW; Nomeir, A; Radwanski, E; Reidenberg, P; Saano, V | 1 |
| Ciuffetti, G; Coata, G; Cosmi, EV; Di Renzo, GC; Lombardini, R; Ventura, F | 1 |
| Daume, E; Doss, MO; Düsterberg, B; Frank, M; Gross, U; Honcamp, M | 1 |
| Banharnsupawat, L; Charoenvisal, C; Kaewsuk, O; Koetsawang, S; Punnahitanont, S; Singhakovin, S | 1 |
| Bachorik, PS; Moutos, DM; Wallach, EE; Zacur, HA | 1 |
| Bocchinfuso, WP; Hammond, GL; Orava, M; Smith, CL; van den Ende, A; van Enk, A | 1 |
| Berry, E; Brzezinski, A; Grubstein, A; Meirow, D; Reubinoff, BE; Schenker, JG | 1 |
| Dugi, K; Ehlenz, K; Kaffarnik, H; Schaefer, JR; Steinmetz, A; von Wichert, P | 1 |
| Jespersen, J; Petersen, KR; Sidelmann, J; Skouby, SO | 3 |
| Bassol, S; Garza-Flores, J; Martínez, M; Pérez-Palacios, G; Recio, R; Valles de Bourges, V; Vázquez-Estrada, L | 1 |
| Elstein, M; Feichtinger, W; Fitzgerald, C; Lüdicke, F; Müller, U; Spona, J; Williams, C | 1 |
| Abbaticchio, L; Blasi, N; Conte, R; Creanza, V; Ferreri, R; Ierardi, GM; Monterubbianesi, M; Santamato, S | 1 |
| Chez, RA; George, S; O'Brien, WF; Spellacy, WN; Tsibris, AM; Tsibris, JC | 1 |
| Affinito, P; Di Carlo, C; Farace, MJ; Monterubbianesi, M; Nappi, C; Petrillo, G; Primizia, M; Regine, V | 1 |
| Back, DJ; Daume, E; Hammerstein, J; Neiss, A; Power, J; Schindler, AE; Simon, A; Winkler, U | 1 |
| de Vries Robles-Korsen, TJ; Hemrika, DJ; Kennedy, JC; Schoemaker, J; Slaats, EH | 1 |
| Baumann, A; Dibbelt, L; Jütting, G; Knuppen, R; Kuhnz, W; Staks, T | 1 |
| Dobianer, K; Düsterberg, B; Lachnit-Fixson, U; Spona, J | 1 |
| Crook, D; Felton, CV; Godsland, IF; Proudler, AJ; Stevenson, JC; Worthington, M | 1 |
| Alvarado Zaldivar, G; Arenas Arenas, M; Rueda Cisneros, D; Ruiz Astorga, R; Solis Carrera, L; Vázquez Arreola, I | 1 |
| Lamas Flores, R; Pérez Peña, E | 1 |
| Gaspard, U; Leonard, F; Theunissen, L | 1 |
| Hoogland, HJ; Skouby, SO | 1 |
| Andrade Sánchez, A; Bruciaga Montes, V; Chávez López, A; Sereno Colo, JA; Vázquez Benítez, E; Vázquez Martínez, JE | 1 |
| Back, DJ; Daume, E; Hammerstein, J; Neiss, A; Schindler, AE; Simon, A; Ward, S; Winkler, UH | 1 |
| Bounds, W; Guillebaud, J; Newman, B; Nichols, M; Robinson, G | 1 |
| Jespersen, J; Petersen, KP; Skouby, SO | 1 |
| Heger-Mahn, D; Heuner, A; Hümpel, M; Kuhnz, W; Richert, K | 1 |
| Jaeger, A; Kunz, J | 1 |
| Creatsas, G; Serfaty, D; Verougstraete, A; Wildemeersch, D | 1 |
| Borm, GF; Coenen, CM; Rolland, R; Thomas, CM | 1 |
| Teichmann, A | 1 |
| Düsterberg, B; Endrikat, J; Jaques, MA; Mayerhofer, M; Müller, U; Pelissier, C | 1 |
| Gaspard, UJ; Hendrick, JC; Nervo, P; van den Brûle, FA | 1 |
| Albring, M; Brill, K; Kustra, E; Schnitker, J; Teichmann, AT; Wojtynek, P | 1 |
| Bonnar, J; Norris, LA | 1 |
| Haaber, AB; Jepsen, PV; Petersen, KR; Skouby, SO | 1 |
| Mango, D; Manna, P; Miggiano, GA; Ricci, S; Serra, GB | 1 |
| Düsterberg, B; Ellman, H; Mühe, B; Müller, U; Rowe, E | 1 |
| Düsterberg, B; Endrikat, J; Schindler, AE; Winkler, UH | 1 |
| Higgins, JE; Rosenberg, MJ; Waugh, MS | 1 |
| Düsterberg, B; Elstein, M; Feichtinger, W; Lüdicke, F; Müller, U; Spona, J; Sullivan, H | 1 |
| Lippert, TH; Lorkowski, G; Mück, AO; Seeger, H; Teichmann, AT | 1 |
| Beisiegel, U; Brill, K; Jene, A; Leidenberger, F; Then, A; Wünsch, C | 1 |
| Handler, S; Huber, J; Kapiotis, S; Loner, U; Quehenberger, P; Schneider, B; Speiser, W | 1 |
| Adler, M; Cremer, M; Gay, F; Schmit, A; Van Gossum, A | 1 |
| Düsterberg, B; Endrikat, J; Müller, U | 1 |
| Stanczyk, FZ | 1 |
| Buron Fernández, MR; Gómez Sánchez-Biezma, C; Pintor Holguín, E; Sáez Noguero, F | 1 |
| Bruppacher, R; Heinemann, LA; Lewis, MA; MacRae, KD; Spitzer, WO | 1 |
| Blais, L; Cusson, J; Heinemann, L; Lewis, M; Spitzer, WO; Suissa, S | 1 |
| Andreula, C; Ciccone, M; Nicoletti, G; Pugliese, D; Triggiani, G | 1 |
| Lete, I; Morales, P | 1 |
| Creatsas, G; Deligeoroglou, E; Digenopoulou, L; Kallipolitis, G; Kontopoulou-Griva, I; Michalas, S; Milingos, S; Tsangaris, A | 1 |
| Bulten, J; Coenen, CM; Hollanders, JM; Rolland, R; Spielmann, D | 1 |
| Bar-Hava, I; Ben-Rafael, Z; Dekel, A; Dicker, D; Kauschansky, A; Orvieto, R; Yeshaya, A | 1 |
| Brosens, I; Deprest, J; Elomaa, K; Lähteenmäki, P; Moorrees, M; Rolland, R; Tuominen, J | 1 |
| Albring, M; Bidlingmaier, F; Brill, K; Siekmann, A; Siekmann, L | 1 |
| Gross, W; Jung-Hoffmann, C; Kuhl, H; Wiegratz, I | 1 |
| Gimes, G; Valent, S | 1 |
| Bahamondes, L; Baracat, EC; da Cunha, DC; de Andrade, RP; de Melo, NR; Guazelli, CA; Halbe, HW; Lemgruber, M; Petracco, A | 1 |
| Bar, J; Bar-Hava, I; Ben-Rafael, Z; Dicker, D; Kaplan, B; Orvieto, R; Yeshaya, A | 1 |
| Serfaty, D; Vree, ML | 1 |
| Aleandri, V; Salvi, M; Spina, V | 1 |
| Farmer, RD; Lawrenson, R; Leydon, GM; Todd, J; Williams, TJ | 1 |
| Elstein, M; Fitzgerald, C; Spona, J | 1 |
| Elstein, M; Furniss, H; Spona, J; Sullivan, H | 1 |
| Fauser, BC; van Heusden, AM | 1 |
| Alfthan, H; Paetau, A; Poranen, A; Sane, T; Stenman, UH; Tiitinen, A; Välimäki, MJ | 1 |
| Düsterberg, B; Endrikat, J; Gerlinger, C; Ruebig, A; Strowitzki, T | 1 |
| Elomaa, K; Lähteenmäki, P | 1 |
| Cusson, J; Heinemann, L; Lewis, M; Rainville, B; Spitzer, WO; Suissa, S | 1 |
| Diab, KM; Zaki, MM | 1 |
| Buicu, C; Gaspard, U; van den Brûle, F | 1 |
| Ajossa, S; Floris, S; Guerriero, S; Mannias, M; Melis, GB; Orrù, M; Paoletti, AM; Vacca, AM | 1 |
| Fenólio, JC; Ferreira, AC; Franceschini, SA; Montes, MB; Toloi, MR | 1 |
| Busse, R; Herkert, O; Kuhl, H; Schini-Kerth, VB | 1 |
| Kivistö, KT; Laine, K; Manninen, P; Neuvonen, PJ; Palovaara, S; Tapanainen, P | 1 |
| Bertoli, G; Di Lieto, A; Mancone, M; Montoneri, C; Perrone, G; Pietrobattista, P; Sbrignadello, C; Tomassini, A; Zarbo, G; Zichella, L | 1 |
| Albornoz, H; Albrecht, G; Alvarado, A; Bahamondes, L; Bassol, S; Celis, C; Cravioto, MC; de Melo, NR; Isaia, B; Kesseru, E; Mendes, J; Montaño, R; Novelli, J; Peralta, O; Petracco, A; Reyes-Marquez, R; Soares, A | 1 |
| Elomaa, K; Lähteenmäki, P; Ranta, S; Tuominen, J | 2 |
| Ahola, L; Eriksson, CJ; Sarkola, T; von der Pahlen, B | 1 |
| Bianchi, C; Guardianelli, F; Lello, S; Monterubbianesi, M; Simonelli, C | 1 |
| Bersi, C; Carmassi, F; De Negri, F; Fruzzetti, F; Genazzani, AR; Ricci, C | 1 |
| Agnello, C; Caruso, S; Grillo, C; Intelisano, G; Maiolino, L; Serra, A | 1 |
| Cronin, M; Düsterberg, B; Endrikat, J; Gerlinger, C; Ruebig, A; Schmidt, W | 3 |
| Cianci, A; Ciotta, L; De Leo, V; la Marca, A; Lucani, B; Morgante, G; Nami, R; Petraglia, F | 1 |
| Düsterberg, B; Endrikat, J; Gerlinger, C; Holler, T; Klipping, C; Ruebig, A; Schmidt, W | 1 |
| Elstein, M; Lüdicke, F; Spona, J; Sullivan, H | 1 |
| Algra, A; Cats, VM; Helmerhorst, FM; Kemmeren, JM; Rosendaal, FR; Tanis, BC; van den Bosch, MA; van der Graaf, Y | 1 |
| Cronin, M; Düsterberg, B; Endrikat, J; Gerlinger, C; Rosenbaum, P; Ruebig, A; Wessel, J | 1 |
| Dubey, RK; Jäger, AW; Keller, PJ; Merki-Feld, GS; Rosselli, M | 1 |
| Brocco, G; Franchini, M; Guidi, G; Lippi, G; Manzato, F | 1 |
| Fanelli, M; Laricchia, L; Orsini, G | 1 |
| Cioni, R; Fambrini, M; Marchionni, M; Noci, I; Scarselli, G | 1 |
| Hasegawa, M; Inês, M; Kassab, NM; Kedor-Hackmann, ER; Santoro, RM | 1 |
| Imthurn, B; Keller, PJ; Merki-Feld, GS | 1 |
| Lech, MM; Ostrowska, L | 1 |
| Jaisamrarn, U; Kriengsinyot, R; Taneepanichskul, S | 1 |
| Demeyer, F; Gaspard, UJ; Lefebvre, P; Lüdicke, F; Scheen, A | 1 |
| Caruso, S; Cocuzza, S; Farina, M; Intelisano, G; Maiolino, L; Rugolo, S; Serra, A | 1 |
| Amir, O; Biron-Shental, T; Kishon-Rabin, L; Muchnik, C | 1 |
| Acunzo, G; Bifulco, G; Di Carlo, C; Di Spiezio Sardo, A; Guida, M; Nappi, C; Tommaselli, GA | 1 |
| Ahued, JR; Albrecht, G; Alvarado, G; Arreola, RG; Bassol, S; Botti, G; Botto, E; Carneiro de Oliveira, H; Celis-Gonzalez, C; Cifuentes, R; Diogenes Holanda Yazlle, ME; Fernandez, M; Figueroa Casas, PR; Flores, JG; Gomez, J; Gurucharri, C; Heredia, MG; Lastreto, E; Lopez, CR; Nañez, M; Nuñez de Pierro, A; Ortiz, OC; Peña, EP; Penagos, G; Percossi, G; Prieto, G; Reyes-Marquez, R; Ricalde, RL; Salazar, G; Silva, J; Torres, LA; Tozzini, RI | 1 |
| Alexandersen, P; Christiansen, C; Haarbo, J; Jespersen, J; Skouby, SO; Zandberg, P | 1 |
| Oosterbaan, HP | 1 |
| Helmerhorst, E; Klipping, C; Kluft, C; Spielmann, D; van Aken, B; van der Mooren, MJ | 1 |
| Agnello, C; Caruso, S; Cianci, A; Di Mari, L; Farina, M; Intelisano, G | 1 |
| Arsenijević, S; Grujicić, D; Loncar, D; Milosević-Djordjević, O; Zivanović, A | 1 |
| Cascella, T; Colao, A; Di Biase, S; Labella, D; Lombardi, G; Orio, F; Palomba, S; Pellicano, M; Russo, T; Savastano, S; Tauchmanovà, L; Zullo, F | 1 |
| Kulik-Rechberger, B; Pieprzowska-Białek, A; Rechberger, T; Skorupski, P; Tomaszewski, J | 1 |
| Lech, MM; Swiatek, EJ | 1 |
| De Zegher, F; Ibáñez, L | 1 |
| del Marmol, V; Gertsen, K; Teichmann, A | 1 |
| Düsterberg, B; Endrikat, J; Rosenbaum, P; Wessel, J | 1 |
| Cruz, AM; da Cunha Bastos, A; Fabrini, P; Machado, RB; Maia, E | 1 |
| Di Spiezio Sardo, A; Giordano, E; Greco, E; Guida, M; Nappi, C; Tommaselli, GA | 1 |
| Iacheva, T; Milchev, N; Terzhumanov, R; Uchikova, E | 1 |
| Faustmann, T; Gerlinger, C; Heger-Mahn, D; Klipping, C; Warlimont, C | 1 |
| Aldrighi, JM; Barbieri, M; de Araújo, FF; Guazzelli, CA; Lindsey, PC; Petta, CA | 1 |
| Guzelmeric, K; Seker, N; Turan, C; Unal, O | 1 |
| Backman, JT; Granfors, MT; Laitila, J; Neuvonen, PJ | 1 |
| Baracat, EC; Barbosa, IC; Faggion, D; Filho, CI | 1 |
| Aldrighi, JM; Bahamondes, L; De Campos, LS; Eluf Gebara, OC; Petta, CA | 1 |
| Cavenague, G; Machado, RB; Maia, E; Tachotti, F | 1 |
| Cagiano, R; Sabatini, R | 1 |
| Kubán, V; Matejícek, D | 1 |
| Agnello, C; Arcidiacono, A; Caruso, S; Cianci, A; Di Mari, L; Maiolino, L; Ruta, S; Serra, A | 1 |
| Oranratanaphan, S; Taneepanichskul, S | 1 |
| Chen, D; Sun, Y; Wang, J; Zhang, Q; Zhang, X; Zhang, Z; Zheng, Y | 1 |
| Pehlivanov, B; Uchikova, E | 1 |
| Chao, A; Chao, AS; Lai, CH; Wang, CJ; Wang, TH; Wu, CT | 1 |
| Iakov, B | 1 |
| Frascà, C; Keramyda, A; Mabrouk, M; Manuzzi, L; Montanari, G; Seracchioli, R; Venturoli, S | 1 |
| Adali, E; Birol, F; Suer, N; Yildizhan, B; Yildizhan, R; Yoruk, P | 1 |
| Gao, Y; Liang, J; Liu, J; Xiao, Y | 1 |
| Jakov, B | 1 |
| Radinski, G | 1 |
| Cabral, CA; Cardoso, LE; Sampaio, FJ; Zamboni, MJ | 1 |
| Huo, T; Li, N; Sun, X; Sun, Y; Xiong, Z; Zheng, Y | 1 |
| Bollea, MR; Capozzolo, T; Marziali, M; Piccione, E; Pietropolli, A; Sesti, F | 1 |
| Athayde, C; Casoy, J; Correia, T; Coutinho, EM; Maia, H; Valente, J | 1 |
| Dautin, G; Duvillard, L; Florentin, E; Gambert, P; Jeannin, A; Lagrost, L; Pais de Barros, JP; Petit, JM; Vergès, B | 1 |
| Nikolov, A | 1 |
| Dautin, G; Duvillard, L; Florentin, E; Gambert, P; Petit, JM; Vergès, B | 1 |
| Cesar, Mde C; da Silva, E; de Sá, MF; Rebelo, AC; Verlengia, R; Zuttin, RS | 1 |
| Cianci, A; De Leo, V; Di Sabatino, A; Morgante, G; Musacchio, MC; Petraglia, F; Scolaro, V | 1 |
| Battista, R; Bruni, L; Dores, D; Filippeschi, M; Florio, P; Gubbini, G; Marra, E; Moncini, I; Nascetti, D; Petraglia, F | 1 |
| Ding, CG; Ge, QH; Liu, XF; Zhi, XJ; Zhou, Z | 1 |
| Catai, A; Celante, V; de Sá, MF; Rebelo, AC; Salviati, M; Silva, E; Takahashi, A; Tamburús, N | 1 |
| Voelker, R | 1 |
| Candiani, M; DI Puppo, F; Ferrari, S; Garavaglia, E; Giardina, P; Mezzi, G; Persico, P; Tandoi, I; Vigano, P | 1 |
| Lages, L; Maier, PS; Mattiello, SS; Spritzer, PM | 1 |
| Jürimäe, J; Jürimäe, T; Kalytka, S; Mäestu, J; Purge, P; Shakhlina, L; Vaiksaar, S | 1 |
| Dmitrovic, R; Kunselman, AR; Legro, RS | 1 |
| Caroppo, E; D'Amato, G | 1 |
| Cheewadhanaraks, S; Choksuchat, C; Dhanaworavibul, K; Liabsuetrakul, T | 1 |
| Horváth, D; Kovács, GL; Lőcsei, Z; Rácz, K; Szabolcs, I; Toldy, E | 1 |
| Maier, PS; Spritzer, PM | 1 |
| Jaisamrarn, U; Jaithitivit, L; Taneepanichskul, S | 1 |
| Cerda, A; da Silva, E; Hirata, MH; Hirata, RD; Kunz, VC; Rebelo, AC; Silva de Sá, MF; Tamburus, NY; Verlengia, R | 1 |
| Bizior-Frymus, D; Dyja, R; Jonderko, K; Kamińska, M; Kasicka-Jonderko, A; Skałba, P | 1 |
| Heger-Mahn, D; Junge, W; Merz, M; Trummer, D | 1 |
| Gutiérrez-Montero, O; Reche-Sainz, JA; Rivera-Zori, M | 1 |
| Grunert, J; Merz, M | 1 |
| de Bastos, M; Dekkers, OM; Helmerhorst, FM; Rosendaal, FR; Stegeman, BH; Stijnen, T; Van Hylckama Vlieg, A | 1 |
| Bassol, S; Mellinger, U; Merz, M; Weisberg, E; Wiegratz, I | 1 |
| Bannemerschult, R; Endrikat, J; Gerlinger, C; Marr, J; Mellinger, U; Merz, M; Schellschmidt, I; Trussell, J | 1 |
| Bangerter, K; Merz, M; Reinecke, I; Westhoff, CL | 1 |
| Goldammer, M; Ludwig, M; Rohde, B; Winkler, J; Zurth, C | 1 |
| Höchel, J; Ludwig, M; Schuett, B; Zurth, C | 1 |
| Hofmann, B; Merz, M; Reinecke, I; Schuett, B; Zurth, C | 1 |
| Gruber, D; Lanius, V; Merz, M; Serrani, M; Skřivánek, A | 1 |
| Bangerter, K; Kroll, R; Lynen, R; Merz, M | 1 |
| El-Haggar, SM; Mostafa, TM | 1 |
| Nelson, AL | 1 |
| Duijkers, I; Klipping, C; Rautenberg, T; Rohde, B; Waellnitz, K; Zurth, C | 1 |
| Casjens, M; Ludwig, M; Schuett, B; Waellnitz, K; Zurth, C | 1 |
| García-Lara, C; González de Los Santos, R; Gutiérrez-Hernández, RF; Méndez-Novelo, R; Nájera-Aguilar, HA; Rojas-Valencia, MN | 1 |
| Canu, E; Fulghesu, AM; Melis, F; Melis, GB; Murru, G | 1 |
| Cagnacci, A; Cascinu, S; Cortesi, L; Facchinetti, F; Grandi, G; Marcheselli, L; Pavesi, S; Toss, A | 1 |
| Bizeli, R; Cajoeiro, PO; Chacra, APM; Kluthcovsky, ACGC; Okamoto, JM; Schrut, GCA; Stumpf, MAM | 1 |
| Kotlyarova, AA; Popova, NM; Shul'kin, AV; Vinogradov, IY; Yakusheva, EN | 1 |
| Angsuwathana, S; Chotrungrote, B; Jirakittidul, P; Neungton, C; Rattanachaiyanont, M; Thiampong, T | 1 |
9 review(s) available for ethinyl estradiol and gestodene
| Article | Year |
|---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
Pharmacokinetics of gestodene and ethinyl estradiol after oral administration of a monophasic contraceptive.
Topics: Absorption; Administration, Oral; Biological Availability; Biotransformation; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Norpregnenes; Protein Binding; Serum Albumin; Sex Hormone-Binding Globulin | 1990 |
Inhibition of oral contraceptive steroid-metabolizing enzymes by steroids and drugs.
Topics: Animals; Contraceptives, Oral, Hormonal; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme Inhibitors; Ethinyl Estradiol; Humans; Hydroxylation; Norpregnenes; Progestins; Steroid Hydroxylases; Steroids | 1990 |
[What does the micropill bring?].
Topics: Blood Coagulation; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Lipid Metabolism; Norgestrel; Norpregnenes; Ovary; Progesterone Congeners; Risk | 1986 |
Pharmacokinetics of the new progestogens and influence of gestodene and desogestrel on ethinylestradiol metabolism.
Topics: Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Norgestrel; Norpregnenes; Progesterone Congeners | 1997 |
[New forms of hormonal contraception].
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Implants; Ethinyl Estradiol; Female; Humans; Intrauterine Devices; Levonorgestrel; Norpregnenes; Vinyl Compounds | 2000 |
The role of combined oral contraceptives in the management of acne and seborrhea.
Topics: Acne Vulgaris; Contraceptives, Oral; Contraceptives, Oral, Combined; Dermatitis, Seborrheic; Desogestrel; Ethinyl Estradiol; Female; Humans; Norgestrel; Norpregnenes; Safety; Treatment Outcome | 2004 |
Combined oral contraceptives: venous thrombosis.
Topics: Androstenes; Contraceptives, Oral, Combined; Cyproterone; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Pulmonary Embolism; Randomized Controlled Trials as Topic; Venous Thrombosis | 2014 |
Transdermal contraception methods: today's patches and new options on the horizon.
Topics: Administration, Cutaneous; Animals; Clinical Trials, Phase III as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes | 2015 |
143 trial(s) available for ethinyl estradiol and gestodene
| Article | Year |
|---|---|
Triphasic combination of ethinyl estradiol and gestodene. Long-term clinical trial.
Topics: Adult; Contraceptives, Oral, Combined; Dysmenorrhea; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Menstrual Cycle; Middle Aged; Norpregnenes; Patient Compliance; Pregnancy | 1992 |
A comparative study on the effects of a monophasic pill containing desogestrel plus 20 micrograms ethinylestradiol, a triphasic combination containing levonorgestrel and a monophasic combination containing gestodene on coagulatory factors.
Topics: Adult; Analysis of Variance; Blood Coagulation Factors; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinopeptide A; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Norpregnenes; Progesterone Congeners; Random Allocation | 1991 |
Sex hormone binding globulin, cortisol binding globulin, thyroxine binding globulin, ceruloplasmin: changes in treatment with two oral contraceptives low in oestrogen.
Topics: Carrier Proteins; Ceruloplasmin; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Serum Globulins; Sex Hormone-Binding Globulin; Testosterone; Thyroxine-Binding Proteins | 1991 |
The pharmacokinetics of ethynylestradiol in the presence and absence of gestodene and desogestrel.
Topics: Administration, Oral; Adult; Analysis of Variance; Biological Availability; Desogestrel; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Infusions, Intravenous; Metabolic Clearance Rate; Norpregnenes; Progesterone Congeners; Radioimmunoassay | 1991 |
Desogestrel and gestodene in oral contraceptives: 12 months' assessment of carbohydrate and lipoprotein metabolism.
Topics: Adult; Carbohydrate Metabolism; Contraceptives, Oral; Desogestrel; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Lipoproteins; Metabolism; Norpregnenes; Prospective Studies; Time Factors | 1991 |
[Side effects of oral contraceptives in the first treatment cycle].
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Fertilization in Vitro; Humans; Norgestrel; Norpregnenes; Pilot Projects; Prospective Studies; Retrospective Studies | 1991 |
Open prospective multicenter trial with a new monophasic contraceptive combination containing gestodene.
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Patient Acceptance of Health Care; Prospective Studies; Weight Gain | 1991 |
Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users.
Topics: Adult; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Evaluation; Dysmenorrhea; Ethinyl Estradiol; Female; Humans; Norpregnenes; Ovulation; Thromboembolism | 1991 |
Metabolic changes during treatment with two different progestogens.
Topics: Adult; Blood Coagulation; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Fertilization; Hormones; Humans; Levonorgestrel; Lipid Mobilization; Lipids; Menstrual Cycle; Norgestrel; Norpregnenes; Random Allocation; Reference Values | 1990 |
Changes in lipid metabolism during 12 months of treatment with two oral contraceptives containing 30 micrograms ethinylestradiol and 75 micrograms gestodene or 150 micrograms desogestrel.
Topics: Adolescent; Adult; Cholesterol; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Norpregnenes; Phospholipids; Triglycerides | 1990 |
Protein binding of active ingredients and comparison of serum ethinyl estradiol, sex hormone-binding globulin, corticosteroid-binding globulin, and cortisol levels in women using a combination of gestodene/ethinyl estradiol (Femovan) or a combination of d
Topics: Adult; Biological Availability; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Norpregnenes; Progesterone Congeners; Protein Binding; Randomized Controlled Trials as Topic; Reference Values; Sex Hormone-Binding Globulin; Transcortin | 1990 |
Estrogenic effect of gestodene- or desogestrel-containing oral contraceptives on lipoprotein metabolism.
Topics: Adult; Arteriosclerosis; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipoproteins; Norpregnenes; Progesterone Congeners; Random Allocation; Reference Values; Risk Factors | 1990 |
Comparative studies of 30 micrograms ethinyl estradiol combined with gestodene and desogestrel on blood coagulation, fibrinolysis, and platelets.
Topics: Adolescent; Adult; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinolysis; Humans; Norpregnenes; Progesterone Congeners; Reference Values | 1990 |
Relative bioavailability of ethinyl estradiol from two different oral contraceptive formulations after single oral administration to 18 women in an intraindividual cross-over design.
Topics: Adult; Biological Availability; Chemistry, Pharmaceutical; Contraceptives, Oral; Desogestrel; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Humans; Norpregnenes; Random Allocation | 1990 |
Effects of oral contraceptives on lipid metabolism.
Topics: Adult; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipids; Norpregnenes; Triglycerides | 1990 |
Low-dose oral contraceptives lower plasma levels of apolipoprotein E.
Topics: Adolescent; Adult; Apolipoproteins A; Apolipoproteins B; Apolipoproteins E; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Norgestrel; Norpregnenes; Triglycerides | 1990 |
Intra- and interindividual variations in contraceptive steroid levels during 12 treatment cycles: no relation to irregular bleedings.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Multivariate Analysis; Norpregnenes; Progesterone Congeners; Uterine Hemorrhage | 1990 |
Changes in coagulation and fibrinolysis variables during use of two oral contraceptives containing the same dose of ethinyl estradiol and either gestodene or desogestrel.
Topics: Adult; Blood Coagulation; Ceruloplasmin; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Factor VII; Female; Fibrinolysis; Humans; Norpregnenes; Peptides; Progesterone Congeners; Sex Hormone-Binding Globulin; Tissue Polypeptide Antigen | 1990 |
A double-blind comparison of the efficacy and acceptability of Femodene and Microgynon-30.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Hypertension; Menstrual Cycle; Multicenter Studies as Topic; Norgestrel; Norpregnenes; Patient Dropouts; Random Allocation; United Kingdom | 1990 |
Clinical acceptability of monophasic gestodene.
Topics: Adult; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Drug Evaluation; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Patient Dropouts; Pregnancy | 1990 |
Clinical experience with a low-dose oral contraceptive containing gestodene.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Ethinyl Estradiol; Evaluation Studies as Topic; Female; Humans; Menstrual Cycle; Norpregnenes; Thromboembolism | 1990 |
Effects of two triphasic oral contraceptives containing ethinylestradiol plus levonorgestrel or gestodene on blood coagulation and fibrinolysis.
Topics: Adult; Blood Coagulation; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Sequential; Ethinyl Estradiol; Female; Fibrinolysis; Humans; Levonorgestrel; Norgestrel; Norpregnenes | 1989 |
Metabolic effects of three new low-dose pills: a six-month experience.
Topics: Adult; Androgen Antagonists; Blood Glucose; Body Weight; Cholesterol; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Norpregnenes; Progesterone Congeners; Random Allocation; Reference Values; Triglycerides | 1989 |
Effects of seven low-dose combined contraceptives on vitamin B6 status.
Topics: Adolescent; Adult; Aspartate Aminotransferases; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Desogestrel; Erythrocytes; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Progestins; Pyridoxal Phosphate; Pyridoxine; Time Factors | 1989 |
[Emergency ambulatory treatment of dysfunctional metrorrhagia in adolescents].
Topics: Adolescent; Ambulatory Care; Drug Combinations; Drug Evaluation; Emergencies; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Metrorrhagia; Norethindrone; Norethindrone Acetate; Norgestrel; Norpregnenes | 1989 |
Comparison of two monophasic oral contraceptives: gestodene/ethinyl estradiol versus desogestrel/ethinyl estradiol.
Topics: Adult; Blood Pressure; Body Weight; Breast; Clinical Trials as Topic; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Follow-Up Studies; Headache; Humans; Menstrual Cycle; Multicenter Studies as Topic; Nausea; Norpregnenes; Random Allocation | 1989 |
A clinical overview of a new triphasic contraceptive containing gestodene.
Topics: Adult; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Europe; Female; Humans; Menstrual Cycle; Multicenter Studies as Topic; New Zealand; Norethindrone; Norpregnenes; Patient Compliance; South America | 1989 |
Effect of two monophasic oral contraceptives containing gestodene or desogestrel on serum lipoprotein lipid levels.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipoproteins; Norpregnenes; Random Allocation; Triglycerides | 1989 |
A study comparing a gestoden triphasic formulation with a fixed combination OC.
Topics: Blood Coagulation; Blood Pressure; Body Weight; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Ethinyl Estradiol; Female; Humans; Lipoproteins; Liver; Liver Function Tests; Norpregnenes | 1989 |
[Oral contraception with low-dose progestagen].
Topics: Clinical Trials as Topic; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Norpregnenes; Pregnancy | 1989 |
Development and application of a radioimmunoassay of the new progestagen gestodene.
Topics: Analysis of Variance; Chromatography, High Pressure Liquid; Contraceptives, Oral, Hormonal; Cross Reactions; Ethinyl Estradiol; Female; Humans; Immune Sera; Norpregnenes; Progestins; Radioimmunoassay; Therapeutic Equivalency | 1989 |
Blood coagulation with a combination pill containing gestodene and ethinyl estradiol.
Topics: Adolescent; Adult; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone Congeners; Stereoisomerism | 1987 |
Clinical and metabolic effects of gestodene and levonorgestrel.
Topics: Adolescent; Adult; Blood Glucose; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Longitudinal Studies; Menstrual Cycle; Norgestrel; Norpregnenes; Progesterone Congeners; Random Allocation; Stereoisomerism | 1987 |
Oral contraception with a triphasic combination of gestodene and ethinyl estradiol: results of a multicenter clinical study.
Topics: Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation; Multicenter Studies as Topic; Norgestrel; Norpregnenes; Progesterone Congeners; Stereoisomerism | 1987 |
Effects of three low-dose oral contraceptive formulations on lipid metabolism.
Topics: Adolescent; Adult; Arteriosclerosis; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Norgestrel; Norpregnenes; Prospective Studies; Random Allocation | 1987 |
Effect of two oral contraceptives containing 30 micrograms ethinylestradiol and 75 micrograms gestodene or 150 micrograms desogestrel upon various hormonal parameters.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Norpregnenes; Prolactin; Time Factors | 1988 |
Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins.
Topics: Adolescent; Adult; Androgens; Androstane-3,17-diol; Androstenedione; Carrier Proteins; Contraceptives, Oral; Contraceptives, Oral, Combined; Corticosterone; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Norgestrel; Norpregnenes; Radioimmunoassay; Sex Hormone-Binding Globulin; Testosterone | 1995 |
Urinary excretion of 6 beta-hydroxycortisol in women during treatment with different oral contraceptive formulations.
Topics: Contraceptives, Oral; Contraceptives, Oral, Combined; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Levonorgestrel; Norpregnenes | 1995 |
Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive.
Topics: Adult; Anticonvulsants; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Felbamate; Female; Humans; Norpregnenes; Phenylcarbamates; Propylene Glycols | 1995 |
Effect of low-dose oral triphasic contraceptives on blood viscosity, coagulation and lipid metabolism.
Topics: Adolescent; Adult; Blood Coagulation; Blood Viscosity; Cardiovascular Diseases; Contraceptives, Oral, Combined; Erythrocyte Deformability; Ethinyl Estradiol; Female; Humans; Lipids; Norpregnenes; Regression Analysis; Risk Factors | 1995 |
Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women.
Topics: Adult; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Multicenter Studies as Topic; Norpregnenes; Prospective Studies; Thailand; Uterine Hemorrhage | 1995 |
Lipoprotein alterations from a triphasic oral contraceptive containing ethinyl estradiol and gestodene. A 12-month trial.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins B; Arteriosclerosis; Cholesterol; Cholesterol, HDL; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Longitudinal Studies; Norpregnenes; Risk Factors; Triglycerides | 1994 |
Serum distribution of two contraceptive progestins: 3-ketodesogestrel and gestodene.
Topics: Adult; Biological Availability; Contraceptives, Oral, Combined; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Norpregnenes; Sex Hormone-Binding Globulin; Transcortin | 1994 |
Effects of low-dose estrogen oral contraceptives on weight, body composition, and fat distribution in young women.
Topics: Adipose Tissue; Adolescent; Adult; Analysis of Variance; Body Composition; Body Mass Index; Body Weight; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Norpregnenes; Probability; Progesterone Congeners; Prospective Studies; Reference Values | 1995 |
Assessment of endothelial function during oral contraception in women with insulin-dependent diabetes mellitus.
Topics: Adult; Contraceptives, Oral, Hormonal; Diabetes Mellitus, Type 1; Endothelium, Vascular; Ethinyl Estradiol; Female; Homeostasis; Humans; Norpregnenes; Plasminogen; Plasminogen Activator Inhibitor 1; Prospective Studies; Proteins; Tissue Plasminogen Activator; von Willebrand Factor | 1994 |
Safety and efficacy of a combined oral contraceptive: gestodene 75 micrograms plus ethinyl estradiol 30 micrograms in Mexican women.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Mexico; Norpregnenes; Prospective Studies; Triglycerides | 1994 |
A comparison of the effects of two monophasic low dose oral contraceptives on the inhibition of ovulation.
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Norpregnenes; Ovulation; Pregnancy; Progesterone | 1994 |
Efficacy, cycle control and side-effects of two monophasic combination oral contraceptives: gestodene/ethinylestradiol and norgestimate/ethinylestradiol.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Italy; Menstrual Cycle; Norgestrel; Norpregnenes | 1993 |
Pharmacokinetics and protein binding of 3-ketodesogestrel and gestodene in the serum of women during 6 cycles of treatment with two low dose oral contraceptives.
Topics: Adolescent; Adult; Blood Proteins; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Norpregnenes; Protein Binding; Sex Hormone-Binding Globulin | 1993 |
[The clinical and lipid metabolic effects of a gestoden- and ethynyl estradiol-based monophasic contraceptive].
Topics: Adolescent; Adult; Chi-Square Distribution; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Lipids; Lipoproteins; Mexico; Norpregnenes; Progesterone Congeners; Prospective Studies | 1993 |
[Hemostatic balance during treatment with the newest contraceptives].
Topics: Adult; Blood Coagulation; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinolysis; Hemostasis; Humans; Norpregnenes; Prospective Studies | 1994 |
[Effect of a combination of gestoden-ethylene estradiol on the endometrium].
Topics: Adult; Contraceptives, Oral, Hormonal; Dose-Response Relationship, Drug; Drug Evaluation; Endometrium; Ethinyl Estradiol; Female; Humans; Norpregnenes | 1993 |
Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women.
Topics: Adult; Blood Coagulation; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrin; Fibrinolysis; Humans; Norpregnenes | 1993 |
Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6 beta-hydroxycortisol.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Drug Interactions; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Immunoenzyme Techniques; Longitudinal Studies; Norpregnenes; Radioimmunoassay; Time Factors; Transcortin | 1993 |
Effect of four combined oral contraceptives on blood pressure in the pill-free interval.
Topics: Adolescent; Adult; Blood Pressure; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Norethindrone; Norpregnenes; Prospective Studies; Time Factors | 1993 |
A single-dose and 3-month clinical-pharmacokinetic study with a new combination oral contraceptive.
Topics: Adult; Blood Proteins; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Kinetics; Menstrual Cycle; Norpregnenes; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone; Transcortin | 1995 |
[Hormonal contraception has no effect on the atherogenicity of blood lipids: results of a prospective open-label multicenter study in 1321 patients].
Topics: Adult; Arteriosclerosis; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Lipids; Norpregnenes; Progesterone Congeners; Prospective Studies | 1996 |
Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives.
Topics: Adult; Androgens; Blood Pressure; Body Weight; Carrier Proteins; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desogestrel; Dihydrotestosterone; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Hydroxyprogesterones; Norgestrel; Norpregnenes; Progesterone Congeners; Prospective Studies; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone | 1995 |
Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Topics: Adolescent; Adult; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Lipids; Norgestrel; Norpregnenes; Progesterone Congeners | 1995 |
A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 20 micrograms ethinylestradiol/150 micrograms desogestrel, with respect to efficacy, cycle control
Topics: Adolescent; Adult; Amenorrhea; Austria; Body Weight; Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Drug Combinations; Drug Tolerance; Dysmenorrhea; Ethinyl Estradiol; Female; France; Headache; Humans; Longitudinal Studies; Menstrual Cycle; Nausea; Norpregnenes; Progesterone Congeners; Time Factors | 1995 |
The influence of the dose of ethinylestradiol in oral contraceptives on follicle growth.
Topics: Adult; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Norpregnenes; Ovarian Follicle; Pregnancy; Prospective Studies; Ultrasonography | 1995 |
Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris.
Topics: Acne Vulgaris; Adolescent; Adult; Androgens; Androstenedione; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Ovary; Sex Hormone-Binding Globulin; Testosterone | 1996 |
A three-year clinical investigation into efficacy, cycle control and tolerability of a new low-dose monophasic oral contraceptive containing gestodene.
Topics: Adolescent; Adult; Amenorrhea; Contraceptives, Oral, Combined; Dysmenorrhea; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Patient Compliance; Pregnancy; Uterine Hemorrhage | 1996 |
A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol.
Topics: Adolescent; Adult; Antithrombin III; Blood Coagulation; Contraceptives, Oral; Ethinyl Estradiol; Female; Fibrin; Fibrinolysis; Hemostasis; Humans; Norpregnenes; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Protein S; Tissue Plasminogen Activator | 1996 |
The effect of desogestrel, gestodene, and other factors on spotting and bleeding.
Topics: Adolescent; Adult; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Progesterone Congeners; Smoking; Uterine Hemorrhage | 1996 |
Shorter pill-free interval in combined oral contraceptives decreases follicular development.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Double-Blind Method; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Norpregnenes; Ovarian Follicle; Ovary; Progesterone; Ultrasonography | 1996 |
Investigation of the influence of two low-dose monophasic oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, on lipid metabolism in an open randomized trial.
Topics: Adolescent; Adult; Apolipoproteins; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estradiol Congeners; Ethinyl Estradiol; Humans; Lipids; Lipoproteins; Norpregnenes; Patient Dropouts; Progesterone Congeners; Tablets | 1996 |
Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
Topics: Adult; Blood Coagulation; Blood Proteins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Factor VIIa; Female; Humans; Norgestrel; Norpregnenes; Prospective Studies; Protein S; Risk Factors; Thromboembolism; Thrombomodulin | 1996 |
A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle control, an
Topics: Adult; Amenorrhea; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Double-Blind Method; Estradiol Congeners; Ethinyl Estradiol; Female; Germany; Humans; Incidence; Menstruation; Norpregnenes; Time Factors; Uterine Hemorrhage | 1997 |
Inhibition of follicular growth by two different oral contraceptives (monophasic and triphasic) containing ethinylestradiol and gestodene.
Topics: Adult; Contraceptives, Oral, Combined; Cross-Over Studies; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Norpregnenes; Ovarian Follicle; Progesterone Congeners; Single-Blind Method; Ultrasonography | 1997 |
Effects of two combined monophasic and triphasic ethinylestradiol/gestodene oral contraceptives on natural inhibitors and other hemostatic variables.
Topics: Adolescent; Adult; Antithrombin III; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estradiol Congeners; Ethinyl Estradiol; Female; Fibrinogen; Hemostasis; Humans; Lupus Coagulation Inhibitor; Norpregnenes; Plasminogen; Progesterone Congeners; Protein C; Prothrombin Time; Time Factors | 1997 |
The effects of a low-dose gestodene-containing oral contraceptive on endometrial histology in healthy women.
Topics: Adult; Biopsy; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Monitoring; Endometrium; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Norpregnenes; Progesterone Congeners | 1996 |
A delayed starting schedule of oral contraception: the effect on the incidence of breakthrough bleeding and compliance in women.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Drug Administration Schedule; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Incidence; Infant, Newborn; Menstrual Cycle; Norpregnenes; Patient Compliance; Progesterone Congeners; Time Factors; Uterine Hemorrhage | 1996 |
Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Drug Administration Schedule; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Menstrual Cycle; Norpregnenes; Ovarian Follicle; Ovulation; Progesterone | 1998 |
Gestodene and desogestrel do not have a different influence on concentration profiles of ethinylestradiol in women taking oral contraceptives--results of isotope dilution mass spectrometry measurements.
Topics: Administration, Oral; Area Under Curve; Biological Availability; Carbon Isotopes; Contraceptives, Oral, Combined; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Humans; Mass Spectrometry; Menstrual Cycle; Nifedipine; Norpregnenes; Reproducibility of Results; Sensitivity and Specificity | 1998 |
Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters.
Topics: Adolescent; Adult; Apolipoproteins B; Cholesterol; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Evaluation; Ethinyl Estradiol; Female; Humans; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Phospholipids; Reference Values; Triglycerides | 1998 |
[Clinical experiences with a gestodene containing oral contraceptive (femoden)].
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Pregnancy | 1998 |
Efficacy and acceptability of two monophasic oral contraceptives containing ethinylestradiol and either desogestrel or gestodene.
Topics: Acne Vulgaris; Adult; Blood Pressure; Body Weight; Brazil; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Progesterone Congeners; Severity of Illness Index; Uterine Hemorrhage | 1998 |
A comparison of the cycle control and tolerability of two ultra low-dose oral contraceptives containing 20 micrograms ethinylestradiol and either 150 micrograms desogestrel or 75 micrograms gestodene.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Menstruation Disturbances; Norpregnenes; Patient Satisfaction; Pregnancy; Progesterone Congeners | 1998 |
Effect of age on the response of the hypothalamo-pituitary-ovarian axis to a combined oral contraceptive.
Topics: Adult; Aging; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Hypothalamus; Middle Aged; Norpregnenes; Ovary; Ovulation; Pituitary Gland; Prospective Studies; Ultrasonography | 1999 |
Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity.
Topics: Adolescent; Adult; Cervix Mucus; Contraceptives, Oral, Synthetic; Drug Combinations; Drug Evaluation; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstrual Cycle; Norpregnenes; Ovarian Follicle; Ovulation; Progesterone Congeners; Ultrasonography | 1999 |
Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Norpregnenes; Ovarian Follicle; Ovary; Pituitary Gland | 1999 |
An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables. Outline of the protocol. Oral Contraceptive and Hemostasis Study Group.
Topics: Blood Coagulation; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Hemostasis; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Peptide Fragments; Prothrombin; Thrombin; Venous Thrombosis | 1999 |
Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Pregnancy; Progesterone Congeners; Prospective Studies; Uterine Hemorrhage | 1999 |
Ovulatory potential of preovulatory sized follicles during oral contraceptive treatment.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Estradiol; Estradiol Congeners; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Norpregnenes; Ovarian Follicle; Ovulation; Progesterone; Progesterone Congeners | 1999 |
Contraception in diabetic women: comparative metabolic study of Norplant, depot medroxyprogesterone acetate, low dose oral contraceptive pill and CuT380A.
Topics: Adult; Blood Coagulation; Blood Glucose; Blood Pressure; Cholesterol; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Implants; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Lipoproteins; Medroxyprogesterone Acetate; Norpregnenes; Prospective Studies | 2000 |
Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women.
Topics: Adult; Amino Acids; Bone Resorption; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Norpregnenes; Osteocalcin; Sex Hormone-Binding Globulin | 2000 |
Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity as measured by midazolam 1'-hydroxylation.
Topics: Adult; Contraceptives, Oral, Hormonal; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Double-Blind Method; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Hydroxylation; Midazolam; Mixed Function Oxygenases; Norpregnenes; Progesterone Congeners | 2000 |
Comparative study on the acceptability of two modern monophasic oral contraceptive preparations: 30 microgram ethinyl estradiol combined with 150 microgram desogestrel or 75 microgram gestodene.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Progesterone Congeners; Prospective Studies | 1999 |
Latin american experience with two low-dose oral contraceptives containing 30 microg ethinylestradiol/75 microg gestodene and 20 microg ethinylestradiol/150 microg desogestrel.
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Headache; Humans; Latin America; Norpregnenes; Pregnancy; Weight Gain | 2000 |
Charcoal treatment and risk of escape ovulation in oral contraceptive users.
Topics: Adolescent; Adult; Antidiarrheals; Charcoal; Contraceptives, Oral, Combined; Diarrhea; Drug Administration Schedule; Enterohepatic Circulation; Ethinyl Estradiol; Female; Humans; Norethindrone; Norethindrone Acetate; Norpregnenes; Ovary; Ovulation; Ultrasonography | 2001 |
The possible role of enterohepatic cycling on bioavailability of norethisterone and gestodene in women using combined oral contraceptives.
Topics: Adult; Biological Availability; Charcoal; Contraceptives, Oral, Combined; Enterohepatic Circulation; Ethinyl Estradiol; Female; Finland; Humans; Norethindrone; Norpregnenes | 2001 |
Lack of effect of alcohol on ethinylestradiol in premenopausal women.
Topics: Adult; Contraceptives, Oral; Cross-Over Studies; Ethanol; Ethinyl Estradiol; Female; Humans; Norpregnenes; Placebos; Premenopause | 2001 |
Clinical trial of a monophasic estroprogestin oral formulation containing 20 micrograms ethinyl estradiol and 75 micrograms gestodene.
Topics: Adult; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Humans; Italy; Norpregnenes; Patient Compliance; Sexuality; Surveys and Questionnaires; Treatment Outcome | 2001 |
A 12-month clinical investigation with a 24-day regimen containing 15 microg ethinylestradiol plus 60 microg gestodene with respect to hemostasis and cycle control.
Topics: Adolescent; Adult; Analysis of Variance; Contraceptives, Oral, Synthetic; Enzyme-Linked Immunosorbent Assay; Ethinyl Estradiol; Female; Hemostasis; Humans; Menstrual Cycle; Norpregnenes; Time Factors; Whole Blood Coagulation Time | 2001 |
Double-blind, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day versus a 21-day low-dose oral contraceptive regimen containing 20 microg ethinyl estradiol and 75 microg gestodene.
Topics: Contraceptives, Oral; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Placebos; Pregnancy; Prospective Studies; Time Factors; Uterine Hemorrhage | 2001 |
Evaluation of plasma levels of renin-aldosterone and blood pressure in women over 35 years treated with new oral contraceptives.
Topics: Adult; Aldosterone; Blood Pressure; Body Weight; Contraceptives, Oral; Drug Evaluation; Ethinyl Estradiol; Female; Humans; Hypertension; Norpregnenes; Renin | 2001 |
Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 microg ethinyl estradiol and 75 microg gestodene and a 21-day regimen with 20 microg ethinyl estradiol and 150 microg desogestrel.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Time Factors; Treatment Outcome; Uterine Hemorrhage | 2001 |
A double-blind comparative study of the effects of a 23-day oral contraceptive regimen with 20 microg ethinyl estradiol and 75 microg gestodene and a 21-day regimen with 30 microg ethinyl estradiol and 75 microg gestodene on hemostatic variables, lipids,
Topics: Adolescent; Adult; Blood Glucose; Carbohydrate Metabolism; Carbohydrates; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Glucose Tolerance Test; Hemostasis; Humans; Lipids; Netherlands; Norpregnenes; Time Factors | 2001 |
Dose finding in a low-dose 21-day combined oral contraceptive containing gestodene.
Topics: Adult; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Norpregnenes; Ovary; Ovulation; Progesterone; Radioimmunoassay; Ultrasonography | 2001 |
Blood pressure stability in a normotensive population during intake of a monophasic oral contraceptive containing 20 microg ethinylestradiol and 75 g gestodene.
Topics: Adolescent; Adult; Blood Pressure; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Norpregnenes; Retrospective Studies | 2001 |
Long-term effects of combined oral contraceptives on markers of endothelial function and lipids in healthy premenopausal women.
Topics: Adult; Cholesterol, HDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cross-Over Studies; Endothelin-1; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Myocardial Infarction; Nitric Oxide; Norpregnenes; Premenopause; Prospective Studies; Statistics, Nonparametric; Time Factors | 2002 |
Effects of two oral contraceptives on plasma levels of nitric oxide, homocysteine, and lipid metabolism.
Topics: Adult; Cholesterol; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Drug Combinations; Ethinyl Estradiol; Female; Homocysteine; Humans; Levonorgestrel; Lipid Metabolism; Lipoproteins; Nitric Oxide; Norpregnenes | 2002 |
Randomized controlled study of the influence of two low estrogen dose oral contraceptives containing gestodene or desogestrel on carbohydrate metabolism.
Topics: Adult; Blood Glucose; C-Peptide; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Fasting; Female; Glucose Tolerance Test; Humans; Insulin; Norpregnenes; Uterine Hemorrhage | 2002 |
Do oral contraceptives improve vocal quality? Limited trial on low-dose formulations.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Speech Acoustics; Voice Quality | 2003 |
Effects of a low-dose and ultra-low-dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study.
Topics: Absorptiometry, Photon; Adult; Amino Acids; Bone Density; Bone Resorption; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Norpregnenes; Osteocalcin; Prospective Studies; Treatment Outcome | 2003 |
An open-label study of the effects of a 24-day regimen of gestodene 60 microg/ethinylestradiol 15 microg on endometrial histological findings in healthy women.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Endometrium; Estrogens; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Time Factors | 1999 |
The safety and contraceptive efficacy of a 24-day low-dose oral contraceptive regimen containing gestodene 60 microg and ethinylestradiol 15 microg.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Estrogens; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Pregnancy | 1999 |
Cycle control, safety and efficacy of a 24-day regimen of gestodene 60 microg/ ethinylestradiol 15 microg and a 21-day regimen of desogestrel 150 microg/ethinylestradiol 20 microg.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Drug Administration Schedule; Estrogens; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes | 1999 |
A comparative study of the effects of gestodene 60 microg/ethinylestradiol 15 microg and desogestrel 150 microg/ethinylestradiol 20 microg on hemostatic balance, blood lipid levels and carbohydrate metabolism.
Topics: Adult; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Glucose Tolerance Test; Hemostasis; Humans; Lipids; Norpregnenes | 1999 |
Sexual behavior of women taking low-dose oral contraceptive containing 15 microg ethinylestradiol/60 microg gestodene.
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Norpregnenes; Prospective Studies; Sexual Behavior; Treatment Outcome | 2004 |
Serum resistin levels in women taking combined oral contraceptives containing desogestrel or gestodene.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Hormones, Ectopic; Humans; Insulin; Middle Aged; Norpregnenes; Resistin; Treatment Outcome | 2004 |
Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity.
Topics: Abdomen; Adipose Tissue; Adolescent; Adult; Androgen Antagonists; Contraceptives, Oral; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Flutamide; Humans; Hypoglycemic Agents; Metformin; Norpregnenes; Obesity; Polycystic Ovary Syndrome | 2004 |
Plasma concentrations of endogenous hormones during one regular treatment cycle with a low-dose oral contraceptive and during two cycles with deliberate omission of two tablets.
Topics: Adult; Contraceptives, Oral, Combined; Drug Administration Schedule; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Germany; Humans; Luteinizing Hormone; Menstrual Cycle; Norpregnenes; Progesterone; Prospective Studies | 2004 |
Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density.
Topics: Adult; Amino Acids; Androstenes; Bone Density; Bone Remodeling; Calcium; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Norpregnenes; Osteocalcin; Progesterone Congeners | 2005 |
Combined ethinylestradiol/gestodene contraceptive patch: two-center, open-label study of ovulation inhibition, acceptability and safety over two cycles in female volunteers.
Topics: Administration, Cutaneous; Adolescent; Adult; Contraceptive Agents; Drug Administration Schedule; Ethinyl Estradiol; Female; Germany; Humans; Menstrual Cycle; Netherlands; Norpregnenes; Ovulation Inhibition; Patient Compliance; Safety; Treatment Outcome | 2004 |
Evaluation of lipid profile in adolescents during long-term use of combined oral hormonal contraceptives.
Topics: Adolescent; Adult; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Lipids; Norpregnenes; Time Factors; Treatment Outcome; Triglycerides | 2005 |
Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Area Under Curve; Caffeine; Clonidine; Contraceptives, Oral, Combined; Cytochrome P-450 CYP1A2 Inhibitors; Drug Synergism; Ethinyl Estradiol; Female; Half-Life; Humans; Norpregnenes; Theophylline | 2005 |
Effects of two different oral contraceptives on total body water: a randomized study.
Topics: Adult; Androstenes; Body Composition; Body Water; Contraceptives, Oral; Electric Impedance; Ethinyl Estradiol; Female; Humans; Norpregnenes; Prospective Studies | 2006 |
Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives.
Topics: Administration, Intravaginal; Adult; Affect; Contraceptive Agents, Female; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Libido; Menstrual Cycle; Norpregnenes; Prospective Studies; Reproduction; Uterine Hemorrhage | 2006 |
A double blind randomized control trial, comparing effect of drospirenone and gestodene to sexual desire and libido.
Topics: Adult; Androgens; Androstenes; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Health Surveys; Humans; Norpregnenes; Patient Satisfaction; Progesterone Congeners; Sexual Behavior; Surveys and Questionnaires; Thailand; Time Factors | 2006 |
Effect of two low-dose gestodene containing monophasic oral contraceptives on hemostasis in Bulgarian women.
Topics: Adolescent; Adult; Blood Coagulation; Blood Coagulation Tests; Bulgaria; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Fibrinolysis; Hemostasis; Humans; Norpregnenes; Prospective Studies | 2008 |
Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial.
Topics: Adult; Combined Modality Therapy; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Sequential; Disease-Free Survival; Drug Administration Schedule; Endometriosis; Ethinyl Estradiol; Female; Humans; Kaplan-Meier Estimate; Laparoscopy; Norpregnenes; Ovarian Diseases; Prospective Studies; Secondary Prevention; Severity of Illness Index; Time Factors; Treatment Outcome; Ultrasonography | 2010 |
Effects of two combined oral contraceptives containing ethinyl estradiol 30 microg combined with either gestodene or drospirenone on hemostatic parameters, lipid profiles and blood pressure.
Topics: Adult; Androstenes; Blood Pressure; Body Mass Index; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Lipids; Norpregnenes; Young Adult | 2009 |
Oral hormonal contraceptives affect the concentration and composition of urinary glycosaminoglycans in young women.
Topics: Adult; Androstenes; Chondroitin Sulfates; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Dermatan Sulfate; Ethinyl Estradiol; Female; Glycosaminoglycans; Heparitin Sulfate; Humans; Norpregnenes | 2009 |
Recurrence rate of endometrioma after laparoscopic cystectomy: a comparative randomized trial between post-operative hormonal suppression treatment or dietary therapy vs. placebo.
Topics: Adult; Combined Modality Therapy; Contraceptives, Oral, Combined; Diet Therapy; Dietary Supplements; Endometriosis; Endometrium; Ethinyl Estradiol; Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; Gynecologic Surgical Procedures; Humans; Laparoscopy; Leuprolide; Minerals; Norpregnenes; Secondary Prevention; Treatment Outcome; Ultrasonography; Uterine Diseases; Vitamins | 2009 |
Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androstenedione; Androstenes; Chlormadinone Acetate; Contraceptives, Oral, Combined; Dehydroepiandrosterone Sulfate; Desogestrel; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Norpregnenes; Polycystic Ovary Syndrome; Progesterone Congeners; Sex Hormone-Binding Globulin; Statistics, Nonparametric; Testosterone; Young Adult | 2010 |
17-Hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) and treatment with oral contraceptive pills in PCOS women without metabolic comorbidities.
Topics: 3-Hydroxysteroid Dehydrogenases; Adolescent; Adult; Aldo-Keto Reductase Family 1 Member C3; Brazil; Contraceptives, Oral, Combined; Drug Therapy, Combination; Ethinyl Estradiol; Female; Genetic Association Studies; Hirsutism; Humans; Hydroxyprostaglandin Dehydrogenases; Hyperandrogenism; Mineralocorticoid Receptor Antagonists; Norpregnenes; Pilot Projects; Polycystic Ovary Syndrome; Polymorphism, Single Nucleotide; Severity of Illness Index; Sex Hormone-Binding Globulin; Spironolactone; Testosterone; Young Adult | 2012 |
Continuous compared with cyclic oral contraceptives for the treatment of primary dysmenorrhea: a randomized controlled trial.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral; Drug Therapy, Combination; Dysmenorrhea; Ethinyl Estradiol; Female; Humans; Norpregnenes; Pain; Pain Measurement; Treatment Outcome; Young Adult | 2012 |
Postoperative depot medroxyprogesterone acetate versus continuous oral contraceptive pills in the treatment of endometriosis-associated pain: a randomized comparative trial.
Topics: Adult; Analgesia; Contraceptives, Oral; Delayed-Action Preparations; Endometriosis; Ethinyl Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norpregnenes; Pain Measurement; Postoperative Care; Treatment Outcome | 2012 |
Investigation of the hemostatic effect of a transdermal patch containing 0.55 mg ethinyl estradiol and 2.1 mg gestodene compared with a monophasic oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel: an open-label, randomize
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Cross-Over Studies; Drug Administration Schedule; Ethinyl Estradiol; Female; Hemostasis; Humans; Levonorgestrel; Norpregnenes; Patient Compliance; Prothrombin Time; Transdermal Patch; Treatment Outcome; Young Adult | 2013 |
Effects of an ethinyl estradiol/gestodene transdermal contraceptive patch on the endometrium: a single-center, uncontrolled study.
Topics: Administration, Cutaneous; Adult; Contraceptive Agents, Female; Drug Administration Schedule; Endometrium; Ethinyl Estradiol; Female; Humans; Norpregnenes; Progestins; Transdermal Patch; Treatment Outcome; Vagina; Young Adult | 2014 |
Effect of a low-dose contraceptive patch on efficacy, bleeding pattern, and safety: a 1-year, multicenter, open-label, uncontrolled study.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Australia; Chile; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Europe; Female; Humans; Medication Adherence; Menstruation; Mexico; Norpregnenes; Pregnancy; Pregnancy, Unplanned; Pregnancy, Unwanted; Time Factors; Transdermal Patch; Young Adult | 2014 |
Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study population.
Topics: Adult; Androstenes; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Estradiol; Ethinyl Estradiol; Europe; Female; Humans; Intention to Treat Analysis; Matched-Pair Analysis; Nandrolone; Norpregnenes; Pregnancy; Pregnancy, Unwanted; Progestins; Risk Assessment; South America; Transdermal Patch; United States; Young Adult | 2014 |
Impact of body mass index on suppression of follicular development and ovulation using a transdermal patch containing 0.55-mg ethinyl estradiol/2.1-mg gestodene: a multicenter, open-label, uncontrolled study over three treatment cycles.
Topics: Adolescent; Adult; Body Mass Index; Contraceptive Agents, Female; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicular Phase; Follow-Up Studies; Humans; Lost to Follow-Up; Norpregnenes; Obesity; Oogenesis; Ovarian Follicle; Overweight; Ovulation Inhibition; Progesterone; Sex Hormone-Binding Globulin; Transdermal Patch; Ultrasonography; Young Adult | 2014 |
Pharmacokinetic drug-drug interaction between ethinyl estradiol and gestodene, administered as a transdermal fertility control patch, and two CYP3A4 inhibitors and a CYP3A4 substrate.
Topics: Adult; Contraceptives, Oral, Synthetic; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Ethinyl Estradiol; Female; Humans; Middle Aged; Norpregnenes; Substrate Specificity; Transdermal Patch; Young Adult | 2015 |
Implications of different application sites on the bioavailability of a transdermal contraceptive patch containing ethinyl estradiol and gestodene: an open-label, randomized, crossover study.
Topics: Adolescent; Adult; Biological Availability; Cross-Over Studies; Ethinyl Estradiol; Female; Humans; Middle Aged; Norpregnenes; Sex Hormone-Binding Globulin; Transdermal Patch | 2014 |
Pharmacokinetic overview of ethinyl estradiol dose and bioavailability using two transdermal contraceptive systems and a standard combined oral contraceptive.
Topics: Adult; Area Under Curve; Biological Availability; Contraceptives, Oral, Combined; Cross-Over Studies; Ethinyl Estradiol; Female; Humans; Norpregnenes; Transdermal Patch | 2014 |
A comparison of bleeding patterns and cycle control using two transdermal contraceptive systems: a multicenter, open-label, randomized study.
Topics: Adolescent; Adult; Amenorrhea; Austria; Contraceptive Agents, Female; Czech Republic; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Incidence; Mastodynia; Menorrhagia; Menstrual Cycle; Metrorrhagia; Netherlands; Norgestrel; Norpregnenes; Patient Dropouts; Progestins; Transdermal Patch; Young Adult | 2015 |
Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menorrhagia; Menstrual Cycle; Metrorrhagia; Norpregnenes; Patient Dropouts; Progestins; Transdermal Patch; United States; Young Adult | 2015 |
A two-centre, open-label, randomised study of ovulation inhibition with three transdermal contraceptive patches, each containing different amounts of ethinyl estradiol and gestodene in healthy, young women.
Topics: Administration, Cutaneous; Adolescent; Adult; Contraceptive Agents, Female; Ethinyl Estradiol; Female; Humans; Norpregnenes; Ovulation Inhibition; Transdermal Patch; Young Adult | 2016 |
Pharmacokinetics and adhesion of a transdermal patch containing ethinyl estradiol and gestodene under conditions of heat, humidity, and exercise: A single-center, open-label, randomized, crossover study.
Topics: Adhesiveness; Administration, Cutaneous; Adolescent; Adult; Area Under Curve; Contraceptives, Oral, Combined; Cross-Over Studies; Drug Combinations; Ethinyl Estradiol; Exercise; Female; Germany; Hot Temperature; Humans; Humidity; Medication Adherence; Metabolic Clearance Rate; Middle Aged; Norpregnenes; Transdermal Patch; Young Adult | 2015 |
The effectiveness of quick starting oral contraception containing nomegestrol acetate and 17-β estradiol on ovulation inhibition: A randomized controlled trial.
Topics: Adult; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Healthy Volunteers; Humans; Megestrol; Menstrual Cycle; Norpregnadienes; Norpregnenes; Ovulation Inhibition; Treatment Outcome; Young Adult | 2020 |
117 other study(ies) available for ethinyl estradiol and gestodene
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Six-month carbohydrate metabolism studies in women using oral contraceptives containing gestodene and ethinyl estradiol.
Topics: Adult; Blood Glucose; Carbohydrate Metabolism; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Insulin; Norpregnenes | 1992 |
Concentration of ethinyl estradiol in the serum of 31 young women following a treatment period of 3 months with two low-dose oral contraceptives in an intraindividual cross-over design.
Topics: Adult; Biological Availability; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Norpregnenes | 1991 |
Single and multiple administration of a new triphasic oral contraceptive to women: pharmacokinetics of ethinyl estradiol and free and total testosterone levels in serum.
Topics: Adult; Contraceptives, Oral, Sequential; Ethinyl Estradiol; Female; Half-Life; Humans; Norpregnenes; Sex Hormone-Binding Globulin; Testosterone; Transcortin | 1991 |
An open prospective study on the effects on carbohydrate metabolism of an oral monophasic contraceptive containing gestodene (WL-70).
Topics: Adolescent; Adult; Blood Glucose; Blood Pressure; Body Mass Index; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Hydrocortisone; Insulin; Longitudinal Studies; Norpregnenes; Prospective Studies; Transcortin | 1991 |
Inhibition of ovulation by low-dose monophasic contraceptive containing gestodene.
Topics: Adult; Contraceptives, Oral, Combined; Depression, Chemical; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstrual Cycle; Norpregnenes; Ovarian Follicle; Ovulation; Progesterone; Ultrasonography | 1990 |
Femodene/Minulet--how different is gestodene?
Topics: Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Norgestrel; Norpregnenes | 1990 |
Time-dependent alterations in lipid metabolism during treatment with low-dose oral contraceptives.
Topics: Adolescent; Adult; Arteriosclerosis; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Lipids; Norpregnenes; Progesterone Congeners; Reference Values; Risk Factors; Time Factors | 1990 |
Comparison of serum ethinyl estradiol, sex-hormone-binding globulin, corticoid-binding globulin and cortisol levels in women using two low-dose combined oral contraceptives.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Norpregnenes; Sex Hormone-Binding Globulin; Time Factors; Transcortin | 1990 |
Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
Topics: Administration, Oral; Adult; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Radioimmunoassay; Sex Hormone-Binding Globulin | 1990 |
Pharmacokinetics and pharmacodynamics of oral contraceptive steroids: factors influencing steroid metabolism.
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Levonorgestrel; Menstrual Cycle; Norgestrel; Norpregnenes; Sex Hormone-Binding Globulin | 1990 |
Protein binding of the contraceptive steroids gestodene, 3-keto-desogestrel and ethinylestradiol in human serum.
Topics: Blood Proteins; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Protein Binding; Radioimmunoassay | 1990 |
[The characteristics of triphasic estrogen-progesterone contraceptives and their theoretical indications].
Topics: Blood Coagulation; Contraceptives, Oral; Drug Tolerance; Estradiol; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Menstrual Cycle; Norpregnenes; Progesterone; Progesterone Congeners | 1990 |
Interaction with the pharmacokinetics of ethinylestradiol and progestogens contained in oral contraceptives.
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Progestins; Transcortin | 1989 |
Inhibition of ovulation by a new low-dose monophasic contraceptive containing gestodene.
Topics: Adult; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Norpregnenes; Ovarian Follicle; Ovulation; Progesterone; Progesterone Congeners; Ultrasonography | 1989 |
Clinical and metabolic effects of a pill containing 30 mcg ethinylestradiol plus 75 mcg gestodene.
Topics: Adult; Blood Coagulation Factors; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Kidney; Lipid Metabolism; Liver; Menstrual Cycle; Norpregnenes | 1989 |
Metabolic investigations with Femodene--an oral contraceptive containing gestodene and ethinyloestradiol.
Topics: Adolescent; Adult; Ceruloplasmin; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; gamma-Glutamyltransferase; Humans; Norpregnenes; Sex Hormone-Binding Globulin; Triglycerides | 1987 |
Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.
Topics: Adult; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Insulin; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Progesterone Congeners; Sex Hormone-Binding Globulin; Stereoisomerism | 1987 |
Pharmacological and endocrine profiles of gestodene.
Topics: Animals; Contraceptives, Oral; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Glucuronidase; Gonadotropin-Releasing Hormone; Mice; Norpregnenes; Ovariectomy; Ovulation; Pituitary Gland; Progesterone Congeners; Rats; Rats, Inbred Strains; Receptors, Estrogen; Receptors, Progesterone | 1987 |
New progestogens in oral contraceptives.
Topics: Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Progesterone Congeners | 1987 |
A new oral contraceptive, Femovan.
Topics: Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Norpregnenes | 1987 |
Comparative trial of the effects on glucose tolerance and lipoprotein metabolism of two new oral contraceptives containing gestoden and desogestrel.
Topics: Adult; Blood Glucose; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Hydrocortisone; Insulin; Lipoproteins; Norpregnenes | 1988 |
Progestogen potency in oral contraceptive pills.
Topics: Breast; Cholesterol, HDL; Contraceptives, Oral, Combined; Endometrium; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norethindrone; Norgestrel; Norpregnenes; Progesterone Congeners | 1987 |
Alterations in the serum levels of gestodene and SHBG during 12 cycles of treatment with 30 micrograms ethinylestradiol and 75 micrograms gestodene.
Topics: Adolescent; Adult; Ethinyl Estradiol; Female; Humans; Norpregnenes; Sex Hormone-Binding Globulin; Time Factors | 1988 |
[Acceptability and secondary effects of a new oral contraceptive containing ethinylestradiol and gestodene].
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Drug Evaluation; Ethinyl Estradiol; Female; Humans; Norpregnenes; Progesterone Congeners; Prospective Studies | 1987 |
The suppression of ovarian function by the new oral contraceptive--Femodene.
Topics: Contraceptives, Oral, Combined; Drug Administration Schedule; Estradiol; Ethinyl Estradiol; Female; Humans; Luteinizing Hormone; Menstrual Cycle; Norpregnenes; Ovulation; Progesterone | 1987 |
Gestoden, an innovative progestogen.
Topics: Blood Pressure; Body Weight; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Menstruation; Norpregnenes | 1987 |
Fibrinopeptide A plasma levels during low-estrogen oral contraceptive treatment.
Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinopeptide A; Humans; Menstrual Cycle; Norpregnenes; Radioimmunoassay | 1984 |
Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Topics: Adult; Age Factors; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Progesterone Congeners; Progestins; Risk Factors; Smoking; Thromboembolism; Time Factors | 1995 |
Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
Topics: Adult; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Incidence; Levonorgestrel; Norpregnenes; Progestins; Risk Factors; Thromboembolism | 1995 |
The effect on blood pressure of a monophasic oral contraceptive containing ethinylestradiol and gestodene.
Topics: Adolescent; Adult; Blood Pressure; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Hypertension; Middle Aged; Norpregnenes; Retrospective Studies | 1995 |
Hormonal oral contraceptives, urinary porphyrin excretion and porphyrias.
Topics: Adult; Aminolevulinic Acid; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Coproporphyrins; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Porphobilinogen; Porphyrias; Porphyrias, Hepatic; Porphyrins; Uroporphyrins | 1995 |
[Oral contraceptive-induced pancreatitis in the hyperchylomicronemia syndrome].
Topics: Acute Disease; Adult; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Hyperlipoproteinemia Type I; Necrosis; Norpregnenes; Pancreatitis; Triglycerides | 1995 |
Clinical evaluation of an oral contraceptive containing Ethinyl-Oestradiol (30 mcg) and Gestoden (75 mcg).
Topics: Adult; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Norpregnenes; Patient Acceptance of Health Care | 1993 |
Carbohydrate metabolism studies after one year of using an oral contraceptive containing gestodene and ethinyl estradiol.
Topics: Adolescent; Adult; Blood Glucose; Carbohydrate Metabolism; Contraceptives, Oral; Ethinyl Estradiol; Fasting; Female; Glucose Tolerance Test; Humans; Insulin; Multivariate Analysis; Norpregnenes; Prospective Studies | 1994 |
Pulsatile luteinizing hormone secretion during the first and the fourth cycle on two different oral contraceptives containing gestodene.
Topics: Adult; Contraceptives, Oral; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Norpregnenes; Periodicity; Progesterone | 1993 |
Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: serum protein binding of gestodene and influence of treatment on free and total testosterone levels in the
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Norpregnenes; Progesterone Congeners; Protein Binding; Serum Albumin, Bovine; Sex Hormone-Binding Globulin; Testosterone | 1993 |
Inhibition of ovulation by a triphasic gestodene-containing oral contraceptive.
Topics: Adult; Contraceptives, Oral, Hormonal; Dose-Response Relationship, Drug; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Norpregnenes; Ovulation; Progesterone | 1993 |
A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
Topics: Adolescent; Adult; Blood; Contraceptives, Oral; Cross-Sectional Studies; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Lipoproteins, HDL; Norpregnenes; Progestins | 1993 |
[Safety, efficacy and control of the menstrual cycle by a monophasic oral contraceptive containing 75 mcg of gestodene and 30 mcg of ethynyl estradiol].
Topics: Contraceptives, Oral; Contraceptives, Oral, Hormonal; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes | 1993 |
Clinical tolerance of a combined monophasic contraceptive agent containing a low-dose of ethinyloestradiol and gestodene in adolescents.
Topics: Adolescent; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes | 1993 |
Ultrasound evaluation of ovarian activity under oral contraceptives.
Topics: Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Norpregnenes; Ovarian Follicle; Ovary; Ultrasonography | 1993 |
[Metabolic effects of oral contraceptives].
Topics: Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinolysis; Glucose; Hemostasis; Humans; Lipid Metabolism; Norpregnenes | 1993 |
European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Topics: Adult; Aging; Cardiovascular Diseases; Contraception; Contraceptives, Oral; Data Collection; Desogestrel; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Estradiol Congeners; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progesterone Congeners; Risk Factors; Smoking; Surveys and Questionnaires | 1995 |
Absence of antisteroid antibodies in oral contraceptive users presenting with vascular events.
Topics: Adolescent; Adult; Androgen Antagonists; Antibodies; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Immunoenzyme Techniques; Levonorgestrel; Middle Aged; Norethindrone; Norpregnenes; Progesterone Congeners; Thrombophlebitis | 1995 |
The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
Topics: Adult; Antithrombin III; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Factor VII; Factor X; Female; Fibrinogen; Hemostasis; Humans; Norpregnenes; Plasminogen; Plasminogen Activator Inhibitor 1; Progestins; Protein C; Tissue Plasminogen Activator | 1996 |
[Diabetes regulation and oral contraceptives. Lipoporotein metabolism in women with insulin dependent diabetes mellitus using oral contraceptives].
Topics: Adolescent; Adult; Blood Glucose; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Diabetes Mellitus, Type 1; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Lipoproteins; Norpregnenes; Prospective Studies | 1996 |
Effect of 17 alpha-ethinylestradiol, levonorgestrel, 3-keto-desogestrel, and gestodene on calcium influx via voltage-gated calcium channels in human aortic smooth muscles.
Topics: Aorta; Calcium; Calcium Channels; Calcium Radioisotopes; Cells, Cultured; Desogestrel; Dose-Response Relationship, Drug; Estradiol Congeners; Ethinyl Estradiol; Humans; Levonorgestrel; Muscle, Smooth, Vascular; Norpregnenes; Progesterone Congeners | 1996 |
Diagnostic efficacy of push-enteroscopy and long-term follow-up of patients with small bowel angiodysplasias.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiodysplasia; Combined Modality Therapy; Drug Therapy, Combination; Electrocoagulation; Endoscopy, Gastrointestinal; Ethinyl Estradiol; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Intestinal Diseases; Intestine, Small; Male; Melena; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Progesterone Congeners; Retrospective Studies; Treatment Outcome | 1996 |
[Deep venous thrombosis associated with the taking of oral contraceptives: the existence of Leiden factor V?].
Topics: Adult; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Factor V; Female; Humans; Mutation; Norpregnenes; Thrombophlebitis | 1997 |
The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women.
Topics: Adolescent; Adult; Austria; Case-Control Studies; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; France; Germany; Humans; Myocardial Infarction; Norpregnenes; Odds Ratio; Progesterone Congeners; Risk Factors; Smoking; Switzerland; United Kingdom | 1997 |
First-time use of newer oral contraceptives and the risk of venous thromboembolism.
Topics: Adult; Austria; Case-Control Studies; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; France; Germany; Humans; Logistic Models; Norpregnenes; Progesterone Congeners; Pulmonary Embolism; Risk Factors; Switzerland; Thrombophlebitis; United Kingdom; Veins | 1997 |
Combined protein C deficiency and protein C activated resistance as a cause of caval, peripheral, and cerebral venous thrombosis--a case report.
Topics: Adult; Anticoagulants; Cerebral Hemorrhage; Cerebral Veins; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Drug Resistance; Estradiol Congeners; Ethinyl Estradiol; Female; Femoral Vein; Follow-Up Studies; Humans; Iliac Vein; Intracranial Embolism and Thrombosis; Norpregnenes; Popliteal Vein; Prevalence; Progesterone Congeners; Protein C; Protein C Deficiency; Thrombosis; Vena Cava, Inferior; Warfarin | 1998 |
Flexible starting schedule for oral contraception: effect on the incidence of breakthrough bleeding and compliance.
Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Incidence; Menstrual Cycle; Norpregnenes; Patient Compliance; Progesterone Congeners; Prospective Studies; Uterine Hemorrhage | 1998 |
[Contraception after heart transplantation].
Topics: Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Heart Transplantation; Humans; Norpregnenes; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Progesterone; Risk Factors | 1998 |
Venous thromboembolic disease and combined oral contraceptives: A re-analysis of the MediPlus database.
Topics: Adolescent; Adult; Body Mass Index; Case-Control Studies; Cohort Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Databases, Factual; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norpregnenes; Odds Ratio; Risk Factors; Smoking; United Kingdom; Venous Thrombosis | 1999 |
Ovarian hyperstimulation caused by gonadotroph adenoma secreting follicle-stimulating hormone in 28-year-old woman.
Topics: Adenoma; Adult; Contraceptives, Oral, Hormonal; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Inhibins; Luteinizing Hormone; Menstruation Disturbances; Norpregnenes; Ovarian Cysts; Pituitary Neoplasms; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Ultrasonography | 1999 |
Recurrent use of newer oral contraceptives and the risk of venous thromboembolism.
Topics: Adult; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Logistic Models; Norgestrel; Norpregnenes; Risk Factors; Venous Thrombosis | 2000 |
Effects of oral contraceptives in vaginal cytology.
Topics: Adult; Age Factors; Cervix Uteri; Chlamydia Infections; Chlamydia trachomatis; Condoms; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Disease Susceptibility; Epithelial Cells; Ethinyl Estradiol; Female; Humans; Life Style; Norpregnenes; Papillomaviridae; Papillomavirus Infections; Risk Factors; Sexual Behavior; Sexual Partners; Socioeconomic Factors; Tumor Virus Infections; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Uterine Cervicitis | 2000 |
The progestin levonorgestrel induces endothelium-independent relaxation of rabbit jugular vein via inhibition of calcium entry and protein kinase C: role of cyclic AMP.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Calcium; Calcium Chloride; Chlormadinone Acetate; Cyclic AMP; Cyclic GMP; Desogestrel; Dose-Response Relationship, Drug; Endothelium, Vascular; Ethinyl Estradiol; In Vitro Techniques; Jugular Veins; Levonorgestrel; Male; Norpregnenes; Potassium Chloride; Progesterone Congeners; Protein Kinase C; Rabbits; Rolipram; Tetradecanoylphorbol Acetate; Thionucleotides; Vasodilation | 2000 |
A prospective study evidencing rhinomanometric and olfactometric outcomes in women taking oral contraceptives.
Topics: Adolescent; Adult; Ammonia; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Follicular Phase; Humans; Luteal Phase; Male; Menstrual Cycle; Norpregnenes; Odorants; Ovulation; Pimpinella; Prospective Studies; Pyridines; Rhinomanometry; Smell; Syzygium | 2001 |
Oral contraceptives and the risk of myocardial infarction.
Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Factor V; Female; Humans; Levonorgestrel; Logistic Models; Middle Aged; Myocardial Infarction; Norpregnenes; Odds Ratio; Point Mutation; Prothrombin; Risk Factors; Smoking | 2001 |
Body weight change during use of a monophasic oral contraceptive containing 20 microg ethinylestradiol and 75 microg gestodene with a comparison of the women who completed versus those who prematurely discontinued intake.
Topics: Adolescent; Adult; Body Weight; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Norpregnenes; Patient Compliance; Progesterone Congeners; Retrospective Studies | 2001 |
Prothrombotic effects and clinical implications of third-generation oral contraceptives use.
Topics: Adult; Antithrombin III; Blood Coagulation Tests; Contraceptives, Oral, Synthetic; Desogestrel; Drug Evaluation; Ethinyl Estradiol; Female; Hemostasis; Humans; Norpregnenes; Protein C; Protein S; Reference Values; Thrombophilia | 2002 |
[Low-dose combination oral contraceptives use in women with uterine leiomyomas].
Topics: Adult; Chi-Square Distribution; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Data Interpretation, Statistical; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Follow-Up Studies; Hematocrit; Humans; Leiomyoma; Menstruation; Middle Aged; Norpregnenes; Progesterone Congeners; Prospective Studies; Time Factors; Ultrasonography; Uterine Neoplasms; Uterus | 2002 |
Fertilisation and implantation failure in an oral contraceptive user.
Topics: Abortion, Spontaneous; Adult; Chorionic Gonadotropin, beta Subunit, Human; Contraceptives, Oral; Embryo Implantation; Endometrium; Ethinyl Estradiol; Female; Humans; Norpregnenes; Ovulation; Pregnancy; Ultrasonography | 2002 |
Determination of steroid hormones in oral contraceptives by high-performance liquid chromatography.
Topics: Calibration; Chromatography, High Pressure Liquid; Contraceptives, Oral; Estradiol Congeners; Ethinyl Estradiol; Levonorgestrel; Norpregnenes; Progesterone Congeners | 2002 |
Effects of low-dose OCs on weight in women with Central European nutritional habits and lifestyle.
Topics: Adult; Body Mass Index; Contraceptives, Oral; Ethinyl Estradiol; Feeding Behavior; Female; Humans; Life Style; Norpregnenes; Nutritional Physiological Phenomena; Poland; Weight Gain | 2002 |
A comparison of cycle control, efficacy, and side effects among healthy Thai women between two low-dose oral contraceptives containing 20 microg ethinylestradio1/75 microg gestodene (Meliane) and 30 microg ethinylestradio1/75 microg gestodene (Gynera).
Topics: Adult; Blood Pressure; Body Weight; Contraceptives, Oral; Dizziness; Ethinyl Estradiol; Female; Humans; Melanosis; Menstrual Cycle; Nausea; Norpregnenes; Thailand; Uterine Hemorrhage; Vomiting | 2002 |
Auditory brainstem response in premenopausal women taking oral contraceptives.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Evoked Potentials, Auditory, Brain Stem; Female; Follicular Phase; Humans; Luteal Phase; Norpregnenes; Premenopause; Prospective Studies; Reaction Time | 2003 |
A 13-month multicenter clinical experience of a low-dose monophasic oral contraceptive containing 20 microg ethinylestradiol and 75 microg gestodene in Latin American women.
Topics: Adolescent; Adult; Argentina; Brazil; Colombia; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Mexico; Norpregnenes; Patient Compliance; Prospective Studies | 2003 |
Lack of difference among progestins on the anti-atherogenic effect of ethinyl estradiol: a rabbit study.
Topics: Animals; Aorta; Arteriosclerosis; Cholesterol; Contraceptives, Oral, Synthetic; Desogestrel; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Levonorgestrel; Norpregnenes; Progestins; Rabbits | 2003 |
[Effect and control of oral contraceptive Minesse (15 mkg EE/60 mkg Gestoden) on menstrual cycle and body weight].
Topics: Adolescent; Adult; Body Weight; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes | 2003 |
Effect of a low-dose ethinylestradiol and gestodene in combination on the frequency of micronuclei in human peripheral blood lymphocytes of healthy women in vivo.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Lymphocytes; Micronuclei, Chromosome-Defective; Norpregnenes; Prospective Studies | 2004 |
Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism?
Topics: Acne Vulgaris; Adenoma; Adolescent; Adrenal Gland Neoplasms; Androgens; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Norpregnenes; Oligomenorrhea; Ovary; Polycystic Ovary Syndrome; Progestins; Treatment Outcome; Ultrasonography | 2004 |
[The effectiveness and acceptability of oral contraceptives (Logest), containing 20 micrograms ethinylestradiol and 75 micrograms gestodene].
Topics: Adolescent; Adult; Contraception Behavior; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Ethinyl Estradiol; Female; Humans; Middle Aged; Norpregnenes; Patient Acceptance of Health Care; Physician-Patient Relations; Poland; Time Factors; Women's Health | 2004 |
Clinical and metabolic aspects of the continuous use of a contraceptive association of ethinyl estradiol (30 microg) and gestodene (75 microg).
Topics: Adolescent; Adult; Amenorrhea; Antithrombin III; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Fibrinogen; Humans; Insulin; Norpregnenes; Plasminogen Activator Inhibitor 1; Prospective Studies; Prothrombin Time; Triglycerides | 2004 |
[The effect of two low dose oral contraceptive with gestodene on the systems of natural inhibitors of coagulation].
Topics: Adolescent; Adult; Blood Coagulation; Blood Coagulation Factor Inhibitors; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Norpregnenes; Prospective Studies | 2004 |
High serum prostate-specific antigen concentrations in hirsute women do not decrease with treatment by the combination of spironolactone and the contraceptive pill.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Biomarkers; Body Mass Index; Contraceptives, Oral; Dehydroepiandrosterone Sulfate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Norpregnenes; Prostate-Specific Antigen; Spironolactone; Testosterone | 2004 |
Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 microg and ethinylestradiol 15 microg (Minesse).
Topics: Adolescent; Adult; Blood Pressure; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Menstruation Disturbances; Norpregnenes; Pregnancy; Prospective Studies; Uterine Hemorrhage | 2006 |
Effect of a combined oral contraceptive containing 20 microg ethinyl estradiol and 75 microg gestodene on hemostatic parameters.
Topics: Adolescent; Adult; Blood Coagulation Tests; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Hemostasis; Humans; Norpregnenes; Risk Factors; Thrombosis | 2006 |
High performance liquid chromatography/ion-trap mass spectrometry for separation and simultaneous determination of ethynylestradiol, gestodene, levonorgestrel, cyproterone acetate and desogestrel.
Topics: Chromatography, High Pressure Liquid; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Levonorgestrel; Norpregnenes; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet | 2007 |
Cytological aspects of the nasal respiratory epithelium in reproductive-age women taking oral contraceptives.
Topics: Adult; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Epithelial Cells; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Nasal Mucosa; Norpregnenes; Prospective Studies; Vagina; Vaginal Smears | 2006 |
Synchronic release of two hormonal contraceptives for about one month from the PLGA microspheres: in vitro and in vivo studies.
Topics: Animals; Carboxymethylcellulose Sodium; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Carriers; Estrogens; Ethinyl Estradiol; Feasibility Studies; Female; Hydrogen-Ion Concentration; In Vitro Techniques; Lactic Acid; Microspheres; Molecular Weight; Norpregnenes; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polysorbates; Random Allocation; Rats; Rats, Sprague-Dawley; Viscosity | 2008 |
Challenge in the management of endometriosis in the canal of Nuck.
Topics: Adult; Contraceptives, Oral, Combined; Danazol; Drug Therapy, Combination; Endometriosis; Ethinyl Estradiol; Female; Humans; Inguinal Canal; Laparoscopy; Norpregnenes; Recurrence; Reoperation; Treatment Outcome | 2009 |
[Role of milligest in clinical practice].
Topics: Clinical Trials as Topic; Contraception; Contraceptives, Oral, Hormonal; Drug Combinations; Ethinyl Estradiol; Female; Humans; Norpregnenes | 2008 |
Double-layer weekly sustained release transdermal patch containing gestodene and ethinylestradiol.
Topics: Administration, Cutaneous; Animals; Delayed-Action Preparations; Drug Delivery Systems; Ethinyl Estradiol; Mice; Norpregnenes; Permeability; Polymers; Rabbits; Skin Absorption; Time Factors | 2009 |
[The place of miligest in the clinical practice ].
Topics: Contraceptives, Oral, Hormonal; Endometrium; Ethinyl Estradiol; Female; Hemostasis; Humans; Lipid Metabolism; Menstrual Cycle; Norpregnenes | 2008 |
[Modern extremely low dose oral contraception with lindynette 20].
Topics: Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Hemostasis; Humans; Lipid Metabolism; Norpregnenes; Ovulation | 2008 |
Development and validation of UPLC-MS/MS method for simultaneous determination of gestodene and ethinyl estradiol in rat plasma.
Topics: Animals; Calibration; Chromatography, High Pressure Liquid; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Indicators and Reagents; Norpregnenes; Plasma; Quality Control; Rats; Reproducibility of Results; Solutions; Spectrometry, Mass, Electrospray Ionization | 2010 |
Activation of NF-kappaB and COX-2 expression is associated with breakthrough bleeding in patients using oral contraceptives in extended regimens.
Topics: Adult; Case-Control Studies; Contraceptives, Oral, Combined; Cyclooxygenase 2; Drug Administration Schedule; Endometrium; Ethinyl Estradiol; Female; Humans; Inflammation; Menorrhagia; Metrorrhagia; Middle Aged; NF-kappa B; Norpregnenes | 2010 |
Increased apolipoprotein AI production rate and redistribution of high-density lipoprotein size induced by estrogen plus progestin as oral contraceptive.
Topics: Adult; Apolipoprotein A-I; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Kinetics; Lipids; Lipoproteins, HDL; Models, Statistical; Norpregnenes; Young Adult | 2009 |
[Influence of the very low dose oral contraception on the blood presure, body weight and general condition of the patients].
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraception; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Norpregnenes; Young Adult | 2009 |
Changes in apolipoprotein B100-containing lipoprotein metabolism due to an estrogen plus progestin oral contraceptive: a stable isotope kinetic study.
Topics: Adolescent; Adult; Apolipoprotein B-100; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Kinetics; Leucine; Lipoproteins, LDL; Norpregnenes; Triglycerides; Young Adult | 2010 |
Effect of low-dose combined oral contraceptive on aerobic capacity and anaerobic threshold level in active and sedentary young women.
Topics: Adult; Anaerobic Threshold; Contraceptives, Oral, Combined; Cross-Sectional Studies; Ethinyl Estradiol; Exercise; Female; Heart Rate; Humans; Norpregnenes; Oxygen Consumption; Sedentary Behavior; Young Adult | 2010 |
A retrospective case-control study comparing hysteroscopic resection versus hormonal modulation in treating menstrual disorders due to isthmocele.
Topics: Adult; Case-Control Studies; Drug Combinations; Ethinyl Estradiol; Female; Hormones; Humans; Hysteroscopy; Menstruation Disturbances; Norpregnenes; Progestins; Retrospective Studies; Uterine Diseases | 2011 |
[Simultaneous determination of gestodene, etonogestrel and ethinylestradiol in plasma by LC-MS/MS following derivatization].
Topics: Animals; Chromatography, Liquid; Desogestrel; Ethinyl Estradiol; Norpregnenes; Rabbits; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2010 |
Influence of third-generation oral contraceptives on the complexity analysis and symbolic dynamics of heart rate variability.
Topics: Adult; Contraceptives, Oral, Synthetic; Electrocardiography; Estrogens; Ethinyl Estradiol; Exercise; Female; Heart Rate; Humans; Information Theory; Nonlinear Dynamics; Norpregnenes; Sedentary Behavior; Statistics, Nonparametric; Young Adult | 2011 |
Risk of blood clots higher for oral contraceptives with certain progestins.
Topics: Androstenes; Contraceptives, Oral; Cyproterone; Denmark; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Progestins; Registries; Risk; Venous Thromboembolism | 2011 |
Continuous low-dose oral contraceptive in the treatment of colorectal endometriosis evaluated by rectal endoscopic ultrasonography.
Topics: Adult; Colonic Diseases; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Drug Combinations; Dysmenorrhea; Dyspareunia; Endometriosis; Endosonography; Ethinyl Estradiol; Female; Humans; Norpregnenes; Pain Measurement; Pelvic Pain; Prospective Studies; Rectal Diseases | 2012 |
Phase of oral contraceptive cycle and endurance capacity of rowers.
Topics: Body Composition; Contraceptives, Oral, Combined; Drug Administration Schedule; Energy Metabolism; Ergometry; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Oxygen; Physical Endurance; Sports; Young Adult | 2011 |
Resumption of ovarian function after 4 years of estro-progestin treatment in a young woman with Crohn's disease and premature ovarian insufficiency: a case report.
Topics: Adult; Amenorrhea; Crohn Disease; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Luteinizing Hormone; Norpregnenes; Ovary; Primary Ovarian Insufficiency; Time Factors; Treatment Outcome; Young Adult | 2012 |
Progestin-dependent effect of oral contraceptives on plasma aldosterone/renin ratio.
Topics: Adult; Aldosterone; Androstenes; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Progestins; Renin; Renin-Angiotensin System; Young Adult | 2012 |
Aromatase gene polymorphism does not influence clinical phenotype and response to oral contraceptive pills in polycystic ovary syndrome women.
Topics: Adult; Androgens; Anovulation; Aromatase; Blood Pressure; Body Mass Index; Contraceptives, Oral; Ethinyl Estradiol; Female; Gene Frequency; Genotype; Hirsutism; Humans; Hyperandrogenism; Norpregnenes; Phenotype; Polycystic Ovary Syndrome; Polymorphism, Single Nucleotide; Spironolactone; Young Adult | 2012 |
Cycle control, safety and acceptability of a new oral contraceptive containing ethinylestradiol 15 micrograms and gestodene 60 micrograms.
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Intention to Treat Analysis; Menstrual Cycle; Norpregnenes; Young Adult | 2012 |
Association of estrogen receptor alpha gene polymorphisms with autonomic modulation of heart rate in users and nonusers of oral contraceptives.
Topics: Adult; Autonomic Nervous System; Blood Pressure; Brazil; Cardiovascular Diseases; Contraceptives, Oral, Combined; Desogestrel; Estrogen Receptor alpha; Estrogens; Ethinyl Estradiol; Female; Genetic Association Studies; Heart Rate; Humans; Introns; Levonorgestrel; Norpregnenes; Polymorphism, Single Nucleotide; Progestins; Risk Factors | 2013 |
Impact of combined oral contraceptives containing ethinylestradiol on the liver microsomal metabolism.
Topics: Acetamides; Adult; Androstenes; Breath Tests; Carbon Radioisotopes; Case-Control Studies; Contraceptives, Oral, Combined; Cyproterone Acetate; Cytochrome P-450 CYP1A2; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Menstrual Cycle; Norgestrel; Norpregnenes; Young Adult | 2013 |
[Acute retinal pigment epitheliitis. Diagnosis using optical coherence tomography].
Topics: Acute Disease; Adolescent; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Fundus Oculi; Humans; Inflammation; Norpregnenes; Remission Induction; Retinal Diseases; Retinal Pigment Epithelium; Tomography, Optical Coherence; Vision Disorders | 2014 |
Cardiovascular risk in Egyptian healthy consumers of different types of combined oral contraceptives pills: A comparative study.
Topics: Adiponectin; Adipose Tissue; Adult; Androstenes; Anthropometry; Cardiovascular Diseases; Chemistry, Pharmaceutical; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Cross-Sectional Studies; Drug Combinations; Egypt; Ethinyl Estradiol; Female; Humans; Leptin; Levonorgestrel; Norpregnenes; Resistin; Risk Factors | 2015 |
gestodene + ethinvlestradiol (APLEEK⁰). No place for a patch containing a third-generation progestin.
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Drug Combinations; Ethinyl Estradiol; Humans; Norpregnenes; Transdermal Patch | 2016 |
Degradation of gestodene (GES)-17α-ethinylestradiol (EE2) mixture by electrochemical oxidation.
Topics: Boron; Contraceptives, Oral, Synthetic; Diamond; Electrochemical Techniques; Electrodes; Estrogens; Ethinyl Estradiol; Norpregnenes; Oxidation-Reduction; Progestins; Waste Disposal, Fluid; Water Pollutants, Chemical | 2016 |
Very low dose of flutamide in the treatment of hyperandrogenism.
Topics: Acne Vulgaris; Adolescent; Androgen Antagonists; Androstenes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Hyperandrogenism; Norpregnenes; Treatment Outcome; Young Adult | 2018 |
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History.
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Breast Neoplasms; Contraceptive Agents; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Incidence; Medical History Taking; Middle Aged; Norpregnenes; Retrospective Studies; Risk Factors; Young Adult | 2018 |
Acute pancreatitis secondary to oral contraceptive-induced hypertriglyceridemia: a case report.
Topics: Adult; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Humans; Hypertriglyceridemia; Norpregnenes; Pancreatitis | 2018 |
[INFLUENCE OF ETHINYLESTRADIOL - GESTODENE COMBINATION ON THE FUNCTIONAL ACTIVITY AND EXPRESSION OF P-GLYCOPROTEIN.]
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Ethinyl Estradiol; Female; Intestine, Small; Liver; Norpregnenes; Rabbits | 2016 |